false 2023 Q3 0000887936 12/31 0 0.0098643 http://fasb.org/us-gaap/2023#AccountsPayableAndAccruedLiabilitiesCurrent http://fasb.org/us-gaap/2023#AccountsPayableAndAccruedLiabilitiesCurrent 0000887936 2023-01-01 2023-09-30 0000887936 2023-10-19 xbrli:shares 0000887936 2023-09-30 iso4217:USD 0000887936 2022-12-31 iso4217:USD xbrli:shares 0000887936 2023-07-01 2023-09-30 0000887936 2022-07-01 2022-09-30 0000887936 2022-01-01 2022-09-30 0000887936 us-gaap:CommonStockMember 2022-12-31 0000887936 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0000887936 us-gaap:RetainedEarningsMember 2022-12-31 0000887936 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-12-31 0000887936 us-gaap:RetainedEarningsMember 2023-01-01 2023-03-31 0000887936 2023-01-01 2023-03-31 0000887936 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-01-01 2023-03-31 0000887936 us-gaap:CommonStockMember 2023-01-01 2023-03-31 0000887936 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-03-31 0000887936 us-gaap:CommonStockMember 2023-03-31 0000887936 us-gaap:AdditionalPaidInCapitalMember 2023-03-31 0000887936 us-gaap:RetainedEarningsMember 2023-03-31 0000887936 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-03-31 0000887936 2023-03-31 0000887936 us-gaap:RetainedEarningsMember 2023-04-01 2023-06-30 0000887936 2023-04-01 2023-06-30 0000887936 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-04-01 2023-06-30 0000887936 us-gaap:CommonStockMember 2023-04-01 2023-06-30 0000887936 us-gaap:AdditionalPaidInCapitalMember 2023-04-01 2023-06-30 0000887936 us-gaap:CommonStockMember 2023-06-30 0000887936 us-gaap:AdditionalPaidInCapitalMember 2023-06-30 0000887936 us-gaap:RetainedEarningsMember 2023-06-30 0000887936 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-06-30 0000887936 2023-06-30 0000887936 us-gaap:RetainedEarningsMember 2023-07-01 2023-09-30 0000887936 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-07-01 2023-09-30 0000887936 us-gaap:CommonStockMember 2023-07-01 2023-09-30 0000887936 us-gaap:AdditionalPaidInCapitalMember 2023-07-01 2023-09-30 0000887936 us-gaap:CommonStockMember 2023-09-30 0000887936 us-gaap:AdditionalPaidInCapitalMember 2023-09-30 0000887936 us-gaap:RetainedEarningsMember 2023-09-30 0000887936 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-09-30 0000887936 us-gaap:CommonStockMember 2021-12-31 0000887936 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0000887936 us-gaap:RetainedEarningsMember 2021-12-31 0000887936 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-12-31 0000887936 2021-12-31 0000887936 us-gaap:RetainedEarningsMember 2022-01-01 2022-03-31 0000887936 2022-01-01 2022-03-31 0000887936 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-01-01 2022-03-31 0000887936 us-gaap:CommonStockMember 2022-01-01 2022-03-31 0000887936 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-03-31 0000887936 srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0000887936 us-gaap:RetainedEarningsMember srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember 2021-12-31 0000887936 srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember 2021-12-31 0000887936 us-gaap:CommonStockMember 2022-03-31 0000887936 us-gaap:AdditionalPaidInCapitalMember 2022-03-31 0000887936 us-gaap:RetainedEarningsMember 2022-03-31 0000887936 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-03-31 0000887936 2022-03-31 0000887936 us-gaap:RetainedEarningsMember 2022-04-01 2022-06-30 0000887936 2022-04-01 2022-06-30 0000887936 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-04-01 2022-06-30 0000887936 us-gaap:CommonStockMember 2022-04-01 2022-06-30 0000887936 us-gaap:AdditionalPaidInCapitalMember 2022-04-01 2022-06-30 0000887936 us-gaap:CommonStockMember 2022-06-30 0000887936 us-gaap:AdditionalPaidInCapitalMember 2022-06-30 0000887936 us-gaap:RetainedEarningsMember 2022-06-30 0000887936 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-06-30 0000887936 2022-06-30 0000887936 us-gaap:RetainedEarningsMember 2022-07-01 2022-09-30 0000887936 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-07-01 2022-09-30 0000887936 us-gaap:CommonStockMember 2022-07-01 2022-09-30 0000887936 us-gaap:AdditionalPaidInCapitalMember 2022-07-01 2022-09-30 0000887936 us-gaap:CommonStockMember 2022-09-30 0000887936 us-gaap:AdditionalPaidInCapitalMember 2022-09-30 0000887936 us-gaap:RetainedEarningsMember 2022-09-30 0000887936 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-09-30 0000887936 2022-09-30 0000887936 us-gaap:SeniorNotesMember fcn:ConvertibleNoteDue2023Member 2023-09-30 xbrli:pure 0000887936 us-gaap:SeniorNotesMember fcn:ConvertibleNoteDue2023Member 2023-08-17 2023-08-17 0000887936 fcn:StockOptionsAndShareBasedAwardsMember 2023-07-01 2023-09-30 0000887936 fcn:StockOptionsAndShareBasedAwardsMember 2022-07-01 2022-09-30 0000887936 fcn:StockOptionsAndShareBasedAwardsMember 2023-01-01 2023-09-30 0000887936 fcn:StockOptionsAndShareBasedAwardsMember 2022-01-01 2022-09-30 0000887936 2023-10-01 2023-09-30 0000887936 2023-01-01 2022-12-31 0000887936 fcn:CorporateFinanceRestructuringMember 2022-12-31 0000887936 fcn:ForensicAndLitigationConsultingMember 2022-12-31 0000887936 fcn:EconomicConsultingMember 2022-12-31 0000887936 fcn:TechnologyMember 2022-12-31 0000887936 fcn:StrategicCommunicationsMember 2022-12-31 0000887936 fcn:CorporateFinanceRestructuringMember 2023-01-01 2023-09-30 0000887936 fcn:ForensicAndLitigationConsultingMember 2023-01-01 2023-09-30 0000887936 fcn:EconomicConsultingMember 2023-01-01 2023-09-30 0000887936 fcn:TechnologyMember 2023-01-01 2023-09-30 0000887936 fcn:StrategicCommunicationsMember 2023-01-01 2023-09-30 0000887936 fcn:CorporateFinanceRestructuringMember 2023-09-30 0000887936 fcn:ForensicAndLitigationConsultingMember 2023-09-30 0000887936 fcn:EconomicConsultingMember 2023-09-30 0000887936 fcn:TechnologyMember 2023-09-30 0000887936 fcn:StrategicCommunicationsMember 2023-09-30 0000887936 us-gaap:CustomerRelationshipsMember 2023-09-30 0000887936 us-gaap:CustomerRelationshipsMember 2022-12-31 0000887936 us-gaap:TrademarksMember 2023-09-30 0000887936 us-gaap:TrademarksMember 2022-12-31 0000887936 us-gaap:ComputerSoftwareIntangibleAssetMember 2023-09-30 0000887936 us-gaap:ComputerSoftwareIntangibleAssetMember 2022-12-31 0000887936 us-gaap:TrademarksMember 2023-09-30 0000887936 us-gaap:TrademarksMember 2022-12-31 0000887936 us-gaap:CarryingReportedAmountFairValueDisclosureMember 2023-09-30 0000887936 us-gaap:FairValueInputsLevel1Member us-gaap:EstimateOfFairValueFairValueDisclosureMember 2023-09-30 0000887936 us-gaap:FairValueInputsLevel2Member us-gaap:EstimateOfFairValueFairValueDisclosureMember 2023-09-30 0000887936 us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueInputsLevel3Member 2023-09-30 0000887936 us-gaap:CarryingReportedAmountFairValueDisclosureMember 2022-12-31 0000887936 us-gaap:FairValueInputsLevel1Member us-gaap:EstimateOfFairValueFairValueDisclosureMember 2022-12-31 0000887936 us-gaap:FairValueInputsLevel2Member us-gaap:EstimateOfFairValueFairValueDisclosureMember 2022-12-31 0000887936 us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueInputsLevel3Member 2022-12-31 0000887936 fcn:ConvertibleNoteDue2023Member 2023-09-30 0000887936 fcn:ConvertibleNoteDue2023Member 2022-12-31 0000887936 fcn:CreditFacilityMember 2023-09-30 0000887936 fcn:CreditFacilityMember 2022-12-31 0000887936 us-gaap:SeniorNotesMember fcn:ConvertibleNoteDue2023Member 2018-08-20 0000887936 us-gaap:SeniorNotesMember fcn:ConvertibleNoteDue2023Member 2023-05-15 2023-05-15 0000887936 us-gaap:SeniorNotesMember fcn:ConvertibleNoteDue2023Member 2023-08-15 2023-08-15 0000887936 us-gaap:SeniorNotesMember fcn:ConvertibleNoteDue2023Member 2023-07-01 2023-09-30 0000887936 us-gaap:SeniorNotesMember fcn:ConvertibleNoteDue2023Member 2023-01-01 2023-09-30 0000887936 us-gaap:SeniorNotesMember fcn:ConvertibleNoteDue2023Member 2022-07-01 2022-09-30 0000887936 us-gaap:SeniorNotesMember fcn:ConvertibleNoteDue2023Member 2022-01-01 2022-09-30 0000887936 us-gaap:RevolvingCreditFacilityMember fcn:CreditFacilityMember us-gaap:LineOfCreditMember 2022-10-31 0000887936 us-gaap:RevolvingCreditFacilityMember fcn:CreditFacilityMember us-gaap:LineOfCreditMember 2022-11-30 0000887936 fcn:CreditFacilityMember us-gaap:LineOfCreditMember 2022-10-31 0000887936 fcn:CreditFacilityMember us-gaap:LineOfCreditMember 2022-11-30 0000887936 srt:MinimumMember fcn:LondonInterbankOfferedRateLIBOR1Member fcn:CreditFacilityMember us-gaap:LineOfCreditMember 2022-11-01 2022-11-30 0000887936 srt:MaximumMember fcn:LondonInterbankOfferedRateLIBOR1Member fcn:CreditFacilityMember us-gaap:LineOfCreditMember 2022-11-01 2022-11-30 0000887936 srt:MinimumMember fcn:CreditFacilityMember us-gaap:BaseRateMember us-gaap:LineOfCreditMember 2022-11-01 2022-11-30 0000887936 srt:MaximumMember fcn:CreditFacilityMember us-gaap:BaseRateMember us-gaap:LineOfCreditMember 2022-11-01 2022-11-30 0000887936 fcn:FederalFundsMember 2022-11-30 0000887936 fcn:SecuredOvernightFinancingRateSOFRMember 2022-11-30 0000887936 srt:MinimumMember fcn:CreditFacilityMember us-gaap:LineOfCreditMember 2023-01-01 2023-09-30 0000887936 srt:MaximumMember fcn:CreditFacilityMember us-gaap:LineOfCreditMember 2023-01-01 2023-09-30 0000887936 fcn:CreditFacilityMember us-gaap:LineOfCreditMember 2023-09-30 0000887936 fcn:CreditFacilityMember us-gaap:LineOfCreditMember 2022-12-31 0000887936 us-gaap:SeniorNotesMember fcn:ConvertibleNoteDue2023Member 2018-08-20 2018-08-20 fcn:lease_option 0000887936 srt:MaximumMember 2023-09-30 0000887936 us-gaap:RestrictedStockMember 2023-01-01 2023-09-30 0000887936 us-gaap:RestrictedStockUnitsRSUMember 2023-01-01 2023-09-30 0000887936 us-gaap:PerformanceSharesMember 2023-01-01 2023-09-30 0000887936 us-gaap:CostOfSalesMember 2023-07-01 2023-09-30 0000887936 us-gaap:CostOfSalesMember 2022-07-01 2022-09-30 0000887936 us-gaap:CostOfSalesMember 2023-01-01 2023-09-30 0000887936 us-gaap:CostOfSalesMember 2022-01-01 2022-09-30 0000887936 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2023-07-01 2023-09-30 0000887936 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2022-07-01 2022-09-30 0000887936 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2023-01-01 2023-09-30 0000887936 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2022-01-01 2022-09-30 0000887936 fcn:TwoThousandSixteenStockRepurchaseProgramMember 2016-06-02 0000887936 fcn:TwoThousandSixteenStockRepurchaseProgramMember 2019-02-21 0000887936 fcn:TwoThousandSixteenStockRepurchaseProgramMember 2020-02-20 0000887936 fcn:TwoThousandSixteenStockRepurchaseProgramMember 2017-05-18 0000887936 fcn:TwoThousandSixteenStockRepurchaseProgramMember 2017-12-01 0000887936 fcn:TwoThousandSixteenStockRepurchaseProgramMember 2020-07-28 0000887936 fcn:TwoThousandSixteenStockRepurchaseProgramMember 2020-12-03 0000887936 fcn:TwoThousandSixteenStockRepurchaseProgramMember 2022-12-01 0000887936 fcn:TwoThousandSixteenStockRepurchaseProgramMember 2023-09-30 0000887936 fcn:TwoThousandSixteenStockRepurchaseProgramMember 2023-07-01 2023-09-30 0000887936 fcn:TwoThousandSixteenStockRepurchaseProgramMember 2022-07-01 2022-09-30 0000887936 fcn:TwoThousandSixteenStockRepurchaseProgramMember 2023-01-01 2023-09-30 0000887936 fcn:TwoThousandSixteenStockRepurchaseProgramMember 2022-01-01 2022-09-30 fcn:segment 0000887936 2023-07-01 2023-07-01 0000887936 fcn:CorporateFinanceSegmentMember 2023-09-30 fcn:numberOfProfessional 0000887936 fcn:FLCSegmentMember 2023-09-30 0000887936 fcn:CorporateFinanceRestructuringMember 2023-07-01 2023-09-30 0000887936 fcn:CorporateFinanceRestructuringMember 2022-07-01 2022-09-30 0000887936 fcn:CorporateFinanceRestructuringMember 2022-01-01 2022-09-30 0000887936 fcn:ForensicAndLitigationConsultingMember 2023-07-01 2023-09-30 0000887936 fcn:ForensicAndLitigationConsultingMember 2022-07-01 2022-09-30 0000887936 fcn:ForensicAndLitigationConsultingMember 2022-01-01 2022-09-30 0000887936 fcn:EconomicConsultingMember 2023-07-01 2023-09-30 0000887936 fcn:EconomicConsultingMember 2022-07-01 2022-09-30 0000887936 fcn:EconomicConsultingMember 2022-01-01 2022-09-30 0000887936 fcn:TechnologyMember 2023-07-01 2023-09-30 0000887936 fcn:TechnologyMember 2022-07-01 2022-09-30 0000887936 fcn:TechnologyMember 2022-01-01 2022-09-30 0000887936 fcn:StrategicCommunicationsMember 2023-07-01 2023-09-30 0000887936 fcn:StrategicCommunicationsMember 2022-07-01 2022-09-30 0000887936 fcn:StrategicCommunicationsMember 2022-01-01 2022-09-30 0000887936 us-gaap:MaterialReconcilingItemsMember 2023-07-01 2023-09-30 0000887936 us-gaap:MaterialReconcilingItemsMember 2022-07-01 2022-09-30 0000887936 us-gaap:MaterialReconcilingItemsMember 2023-01-01 2023-09-30 0000887936 us-gaap:MaterialReconcilingItemsMember 2022-01-01 2022-09-30

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

FORM 10-Q

☒ | QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended September 30, 2023
OR

☐ | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from to
Commission File Number: 001-14875

FTI CONSULTING, INC.
(Exact Name of Registrant as Specified in its Charter)

Maryland |  |  | 52-1261113
(State or Other Jurisdiction of Incorporation or Organization) |  |  | (I.R.S. Employer Identification No.)
555 12th Street NW |  |  |
Washington, |  |  |
DC |  |  | 20004
(Address of Principal Executive Offices) |  |  | (Zip Code)

(202) 312-9100
(Registrant’s telephone number, including area code)

Securities registered pursuant to Section 12(b) of the Act:

Title of each class |  | Trading Symbol |  | Name of each exchange on which registered
Common Stock, $0.01 par value |  | FCN |  | New York Stock Exchange

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer | ☒ | Accelerated filer | ☐
Non-accelerated filer | ☐ | Smaller reporting company | ☐
|  | Emerging growth company | ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒
Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date.

Class | Outstanding at October 19, 2023
Common Stock, $0.01 par value | 35,509,721

FTI CONSULTING, INC. AND SUBSIDIARIES
INDEX

|  | Page
PART I—FINANCIAL INFORMATION
Item 1. | Financial Statements | 3
| Condensed Consolidated Balance Sheets—September 30, 2023 and December 31, 2022 | 3
| Condensed Consolidated Statements of Comprehensive Income—Three and Nine Months Ended September 30, 2023 and 2022 | 4
| Condensed Consolidated Statements of Stockholders’ Equity—Three and Nine Months Ended Septem ber 30, 2023 and 2022 | 5
| Condensed Consolidated Statements of Cash Flows—Nine Months Ended September 30, 2023 and 2022 | 7
| Notes to Condensed Consolidated Financial Statements | 8
Item 2. | Management’s Discussion and Analysis of Financial Condition and Results of Operations | 19
Item 3. | Quantitative and Qualitative Disclosures About Market Risk | 39
Item 4. | Controls and Procedures | 39
PART II—OTHER INFORMATION |
Item 1. | Legal Proceedings | 40
Item 1A. | Risk Factors | 40
Item 2. | Unregistered Sales of Equity Securities and Use of Proceeds | 40
Item 3. | Defaults Upon Senior Securities | 41
Item 4. | Mine Safety Disclosures | 41
Item 5. | Other Information | 41
Item 6. | Exhibits | 42
SIGNATURES | 43

2

PART I—FINANCIAL INFORMATION
FTI Consulting, Inc. and Subsidiaries
Condensed Consolidated Balance Sheets
(in thousands, except per share data)

Item 1. | Financial Statements

| September 30, |  | December 31,
| 2023 |  | 2022
| (Unaudited) |  |
Assets |  |  |
Current assets |  |  |
Cash and cash equivalents | $ | 201,148 |  |  | $ | 491,688 |
Accounts receivable, net | 1,207,016 |  |  | 896,153 |
Current portion of notes receivable | 32,095 |  |  | 27,292 |
Prepaid expenses and other current assets | 126,967 |  |  | 95,469 |
Total current assets | 1,567,226 |  |  | 1,510,602 |
Property and equipment, net | 164,922 |  |  | 153,466 |
Operating lease assets | 202,505 |  |  | 203,764 |
Goodwill | 1,226,356 |  |  | 1,227,593 |
Intangible assets, net | 19,233 |  |  | 25,514 |
Notes receivable, net | 73,673 |  |  | 55,978 |
Other assets | 64,911 |  |  | 64,490 |
Total assets | $ | 3,318,826 |  |  | $ | 3,241,407 |
Liabilities and Stockholders’ Equity |  |  |
Current liabilities |  |  |
Accounts payable, accrued expenses and other | $ | 170,518 |  |  | $ | 173,953 |
Accrued compensation | 481,007 |  |  | 541,892 |
Billings in excess of services provided | 57,006 |  |  | 53,646 |
Total current liabilities | 708,531 |  |  | 769,491 |
Long-term debt, net | 285,000 |  |  | 315,172 |
Noncurrent operating lease liabilities | 217,755 |  |  | 221,604 |
Deferred income taxes | 157,724 |  |  | 162,374 |
Other liabilities | 85,321 |  |  | 91,045 |
Total liabilities | 1,454,331 |  |  | 1,559,686 |
Commitments and contingencies (Note 10) |  |  |
Stockholders’ equity |  |  |
Preferred stock, $0.01 par value; shares authorized — 5,000; none outstanding | — |  |  | — |
Common stock, $0.01 par value; shares authorized — 75,000; shares issued and outstanding 35,510 (2023) and 34,026 (2022) | 355 |  |  | 340 |
Additional paid-in capital | 9,712 |  |  | — |
Retained earnings | 2,033,132 |  |  | 1,858,103 |
Accumulated other comprehensive loss | (178,704) |  |  | (176,722) |
Total stockholders’ equity | 1,864,495 |  |  | 1,681,721 |
Total liabilities and stockholders’ equity | $ | 3,318,826 |  |  | $ | 3,241,407 |

See accompanying notes to condensed consolidated financial statements
3

FTI Consulting, Inc. and Subsidiaries
Condensed Consolidated Statements of Comprehensive Income
(in thousands, except per share data)
(Unaudited)

| Three Months Ended September 30, |  | Nine Months Ended September 30,
| 2023 |  | 2022 |  | 2023 |  | 2022
Revenues | $ | 893,261 |  |  | $ | 775,865 |  |  | $ | 2,564,558 |  |  | $ | 2,254,477 |
Operating expenses |  |  |  |  |  |  |
Direct cost of revenues | 598,804 |  |  | 526,654 |  |  | 1,740,407 |  |  | 1,539,838 |
Selling, general and administrative expenses | 186,088 |  |  | 159,186 |  |  | 556,672 |  |  | 476,097 |
Amortization of intangible assets | 1,340 |  |  | 2,315 |  |  | 4,939 |  |  | 7,320 |
| 786,232 |  |  | 688,155 |  |  | 2,302,018 |  |  | 2,023,255 |
Operating income | 107,029 |  |  | 87,710 |  |  | 262,540 |  |  | 231,222 |
Other income (expense) |  |  |  |  |  |  |
Interest income and other | 5,147 |  |  | 7,771 |  |  | 3,221 |  |  | 10,418 |
Interest expense | (4,474) |  |  | (2,378) |  |  | (10,435) |  |  | (7,468) |
| 673 |  |  | 5,393 |  |  | (7,214) |  |  | 2,950 |
Income before income tax provision | 107,702 |  |  | 93,103 |  |  | 255,326 |  |  | 234,172 |
Income tax provision | 24,385 |  |  | 15,836 |  |  | 62,067 |  |  | 46,156 |
Net income | $ | 83,317 |  |  | $ | 77,267 |  |  | $ | 193,259 |  |  | $ | 188,016 |
Earnings per common share — basic | $ | 2.44 |  |  | $ | 2.29 |  |  | $ | 5.75 |  |  | $ | 5.57 |
Earnings per common share — diluted | $ | 2.34 |  |  | $ | 2.15 |  |  | $ | 5.43 |  |  | $ | 5.25 |
Other comprehensive loss, net of tax |  |  |  |  |  |  |
Foreign currency translation adjustments, net of tax expense of $0 | $ | (18,228) |  |  | $ | (48,475) |  |  | $ | (1,982) |  |  | $ | (95,345) |
Total other comprehensive loss, net of tax | (18,228) |  |  | (48,475) |  |  | (1,982) |  |  | (95,345) |
Comprehensive income | $ | 65,089 |  |  | $ | 28,792 |  |  | $ | 191,277 |  |  | $ | 92,671 |

See accompanying notes to condensed consolidated financial statements
4

FTI Consulting, Inc. and Subsidiaries
Condensed Consolidated Statements of Stockholders’ Equity
(in thousands)
(Unaudited)

|  |  |  |  |  |  |  |  | Accumulated Other Comprehensive Loss |  |
| Common Stock |  | Additional Paid-in Capital |  | Retained Earnings |  |  |
| Shares |  | Amount |  |  |  |  | Total
Balance at December 31, 2022 | 34,026 |  |  | $ | 340 |  |  | $ | — |  |  | $ | 1,858,103 |  |  | $ | (176,722) |  |  | $ | 1,681,721 |
Net income | — |  |  | $ | — |  |  | $ | — |  |  | $ | 47,547 |  |  | $ | — |  |  | $ | 47,547 |
Other comprehensive income: |  |  |  |  |  |  |  |  |  |  |
Cumulative translation adjustment | — |  |  | — |  |  | — |  |  | — |  |  | 9,850 |  |  | 9,850 |
Issuance of common stock in connection with: |  |  |  |  |  |  |  |  |  |  |
Exercise of options | 14 |  |  | — |  |  | 449 |  |  | — |  |  | — |  |  | 449 |
Restricted share grants, less net settled shares of 55 | 55 |  |  | 1 |  |  | (9,514) |  |  | — |  |  | — |  |  | (9,513) |
Stock units issued under incentive compensation plan | — |  |  | — |  |  | 2,274 |  |  | — |  |  | — |  |  | 2,274 |
Purchase and retirement of common stock | (112) |  |  | (1) |  |  | (17,798) |  |  | — |  |  | — |  |  | (17,799) |
Conversion of convertible senior notes due 2023 | — |  |  | — |  |  | (6) |  |  | — |  |  | — |  |  | (6) |
Share-based compensation | — |  |  | — |  |  | 6,365 |  |  | — |  |  | — |  |  | 6,365 |
Reclassification of negative additional paid-in capital | — |  |  | — |  |  | 18,230 |  |  | (18,230) |  |  | — |  |  | — |
Balance at March 31, 2023 | 33,983 |  |  | $ | 340 |  |  | $ | — |  |  | $ | 1,887,420 |  |  | $ | (166,872) |  |  | $ | 1,720,888 |
Net income | — |  |  | $ | — |  |  | $ | — |  |  | $ | 62,395 |  |  | $ | — |  |  | $ | 62,395 |
Other comprehensive income: |  |  |  |  |  |  |  |  |  |  |
Cumulative translation adjustment | — |  |  | — |  |  | — |  |  | — |  |  | 6,396 |  |  | 6,396 |
Issuance of common stock in connection with: |  |  |  |  |  |  |  |  |  |  |
Exercise of options | 21 |  |  | — |  |  | 718 |  |  | — |  |  | — |  |  | 718 |
Restricted share grants, less net settled shares of 13 | 30 |  |  | — |  |  | (2,408) |  |  | — |  |  | — |  |  | (2,408) |
Conversion of convertible senior notes due 2023 | — |  |  | — |  |  | (375) |  |  | — |  |  | — |  |  | (375) |
Share-based compensation | — |  |  | — |  |  | 7,538 |  |  | — |  |  | — |  |  | 7,538 |
Balance at June 30, 2023 | 34,034 |  |  | $ | 340 |  |  | $ | 5,473 |  |  | $ | 1,949,815 |  |  | $ | (160,476) |  |  | $ | 1,795,152 |
Net income | — |  |  | $ | — |  |  | $ | — |  |  | $ | 83,317 |  |  | $ | — |  |  | $ | 83,317 |
Other comprehensive loss: |  |  |  |  |  |  |  |  |  |  |
Cumulative translation adjustment | — |  |  | — |  |  | — |  |  | — |  |  | (18,228) |  |  | (18,228) |
Issuance of common stock in connection with: |  |  |  |  |  |  |  |  |  |  |
Exercise of options | 1 |  |  | — |  |  | 42 |  |  | — |  |  | — |  |  | 42 |
Restricted share grants, less net settled shares of 17 | 14 |  |  | — |  |  | (3,291) |  |  | — |  |  | — |  |  | (3,291) |
Settlement of conversion premium of convertible senior notes due 2023 | 1,461 |  |  | 15 |  |  | (21) |  |  | — |  |  | — |  |  | (6) |
Share-based compensation | — |  |  | — |  |  | 7,509 |  |  | — |  |  | — |  |  | 7,509 |
Balance at September 30, 2023 | 35,510 |  |  | $ | 355 |  |  | $ | 9,712 |  |  | $ | 2,033,132 |  |  | $ | (178,704) |  |  | $ | 1,864,495 |

5

|  |  |  |  |  |  |  |  | Accumulated Other Comprehensive Loss |  |
| Common Stock |  | Additional Paid-in Capital |  | Retained Earnings |  |  |
| Shares |  | Amount |  |  |  |  | Total
Balance at December 31, 2021 | 34,333 |  |  | $ | 343 |  |  | $ | 13,662 |  |  | $ | 1,698,156 |  |  | $ | (128,840) |  |  | $ | 1,583,321 |
Net income | — |  |  | $ | — |  |  | $ | — |  |  | $ | 59,321 |  |  | $ | — |  |  | $ | 59,321 |
Other comprehensive loss: |  |  |  |  |  |  |  |  |  |  |
Cumulative translation adjustment | — |  |  | — |  |  | — |  |  | — |  |  | (6,191) |  |  | (6,191) |
Issuance of common stock in connection with: |  |  |  |  |  |  |  |  |  |  |
Exercise of options | 26 |  |  | — |  |  | 923 |  |  | — |  |  | — |  |  | 923 |
Restricted share grants, less net settled shares of 54 | 134 |  |  | 2 |  |  | (7,836) |  |  | — |  |  | — |  |  | (7,834) |
Stock units issued under incentive compensation plan | — |  |  | — |  |  | 1,664 |  |  | — |  |  | — |  |  | 1,664 |
Purchase and retirement of common stock | (22) |  |  | — |  |  | (3,098) |  |  | — |  |  | — |  |  | (3,098) |
Cumulative effect due to adoption of new accounting standard | — |  |  | — |  |  | (34,131) |  |  | 22,078 |  |  | — |  |  | (12,053) |
Conversion of convertible senior notes due 2023 | — |  |  | — |  |  | (2) |  |  | — |  |  | — |  |  | (2) |
Share-based compensation | — |  |  | — |  |  | 5,967 |  |  | — |  |  | — |  |  | 5,967 |
Reclassification of negative additional paid-in capital | — |  |  | — |  |  | 22,851 |  |  | (22,851) |  |  | — |  |  | — |
Balance at March 31, 2022 | 34,471 |  |  | $ | 345 |  |  | $ | — |  |  | $ | 1,756,704 |  |  | $ | (135,031) |  |  | $ | 1,622,018 |
Net income | — |  |  | $ | — |  |  | $ | — |  |  | $ | 51,428 |  |  | $ | — |  |  | $ | 51,428 |
Other comprehensive loss: |  |  |  |  |  |  |  |  |  |  |
Cumulative translation adjustment | — |  |  | — |  |  | — |  |  | — |  |  | (40,679) |  |  | (40,679) |
Issuance of common stock in connection with: |  |  |  |  |  |  |  |  |  |  |
Exercise of options | 22 |  |  | — |  |  | 687 |  |  | — |  |  | — |  |  | 687 |
Restricted share grants, less net settled shares of 55 | 47 |  |  | — |  |  | (8,907) |  |  | — |  |  | — |  |  | (8,907) |
Conversion of convertible senior notes due 2023 | — |  |  | — |  |  | (11) |  |  | — |  |  | — |  |  | (11) |
Share-based compensation | — |  |  | — |  |  | 6,083 |  |  | — |  |  | — |  |  | 6,083 |
Reclassification of negative additional paid-in capital | — |  |  | — |  |  | 2,647 |  |  | (2,647) |  |  | — |  |  | — |
Balance at June 30, 2022 | 34,540 |  |  | $ | 345 |  |  | $ | 499 |  |  | $ | 1,805,485 |  |  | $ | (175,710) |  |  | $ | 1,630,619 |
Net income | — |  |  | $ | — |  |  | $ | — |  |  | $ | 77,267 |  |  | $ | — |  |  | $ | 77,267 |
Other comprehensive loss: |  |  |  |  |  |  |  |  |  |  |
Cumulative translation adjustment | — |  |  | — |  |  | — |  |  | — |  |  | (48,475) |  |  | (48,475) |
Issuance of common stock in connection with: |  |  |  |  |  |  |  |  |  |  |
Restricted share grants, less net settled shares of 5 | 10 |  |  | — |  |  | (837) |  |  | — |  |  | — |  |  | (837) |
Purchase and retirement of common stock | (128) |  |  | (1) |  |  | (20,431) |  |  | — |  |  | — |  |  | (20,432) |
Share-based compensation | — |  |  | — |  |  | 6,441 |  |  | — |  |  | — |  |  | 6,441 |
Reclassification of negative additional paid-in capital | — |  |  | — |  |  | 14,328 |  |  | (14,328) |  |  | — |  |  | — |
Balance at September 30, 2022 | 34,422 |  |  | $ | 344 |  |  | $ | — |  |  | $ | 1,868,424 |  |  | $ | (224,185) |  |  | $ | 1,644,583 |

See accompanying notes to condensed consolidated financial statements
6

FTI Consulting, Inc. and Subsidiaries
Condensed Consolidated Statements of Cash Flows
(in thousands)
(Unaudited)

| Nine Months Ended September 30,
| 2023 |  | 2022
Operating activities |  |  |
Net income | $ | 193,259 |  |  | $ | 188,016 |
Adjustments to reconcile net income to net cash used in operating activities: |  |  |
Depreciation and amortization | 29,926 |  |  | 27,045 |
Amortization of intangible assets | 4,939 |  |  | 7,320 |
Acquisition-related contingent consideration | 4,263 |  |  | 863 |
Provision for expected credit losses | 21,347 |  |  | 13,101 |
Share-based compensation | 21,412 |  |  | 18,491 |
Amortization of debt issuance costs and other | 1,722 |  |  | 1,588 |
Deferred income taxes | (4,602) |  |  | (9,140) |
Changes in operating assets and liabilities, net of effects from acquisitions: |  |  |
Accounts receivable, billed and unbilled | (333,713) |  |  | (251,280) |
Notes receivable | (22,600) |  |  | 838 |
Prepaid expenses and other assets | (3,252) |  |  | (3,066) |
Accounts payable, accrued expenses and other | (8,895) |  |  | 21,936 |
Income taxes | (347) |  |  | 3,940 |
Accrued compensation | (65,394) |  |  | (67,763) |
Billings in excess of services provided | 3,410 |  |  | 7,672 |
Net cash used in operating activities | (158,525) |  |  | (40,439) |
Investing activities |  |  |
Payments for acquisition of businesses, net of cash received | — |  |  | (6,742) |
Purchases of property and equipment and other | (43,224) |  |  | (38,935) |
Purchase of short-term investment | (24,356) |  |  | — |
Net cash used in investing activities | (67,580) |  |  | (45,677) |
Financing activities |  |  |
Borrowings under revolving line of credit | 725,000 |  |  | 165,000 |
Repayments under revolving line of credit | (440,000) |  |  | (165,000) |
Repayment of convertible notes | (315,763) |  |  | — |
Purchase and retirement of common stock | (20,982) |  |  | (23,530) |
Share-based compensation tax withholdings and other | (14,003) |  |  | (15,663) |
Payments for business acquisition liabilities | (3,651) |  |  | (4,848) |
Deposits and other | 2,319 |  |  | 7,092 |
Net cash used in financing activities | (67,080) |  |  | (36,949) |
Effect of exchange rate changes on cash and cash equivalents | 2,645 |  |  | (44,373) |
Net decrease in cash and cash equivalents | (290,540) |  |  | (167,438) |
Cash and cash equivalents, beginning of period | 491,688 |  |  | 494,485 |
Cash and cash equivalents, end of period | $ | 201,148 |  |  | $ | 327,047 |
Supplemental cash flow disclosures |  |  |
Cash paid for interest | $ | 10,160 |  |  | $ | 8,012 |
Cash paid for income taxes, net of refunds | $ | 67,015 |  |  | $ | 51,353 |
Non-cash investing and financing activities: |  |  |
Issuance of stock units under incentive compensation plans | $ | 2,274 |  |  | $ | 1,664 |
Business acquisition liabilities not yet paid | $ | — |  |  | $ | 5,593 |
Non-cash additions to property and equipment | $ | 1,972 |  |  | $ | 4,970 |

See accompanying notes to condensed consolidated financial statements
7

FTI Consulting, Inc. and Subsidiaries
Notes to Condensed Consolidated Financial Statements
(dollar and share amounts in tables in thousands, except per share data)
(Unaudited)
1. Basis of Presentation
The unaudited condensed consolidated financial statements of FTI Consulting, Inc., including its consolidated subsidiaries (collectively, the “Company,” “we,” “our” or “FTI Consulting”), presented herein, have been prepared in accordance with generally accepted accounting principles in the United States (“GAAP”) and under the rules and regulations of the Securities and Exchange Commission (“SEC”) for interim financial information. Some of the information and footnote disclosures normally included in annual financial statements have been condensed or omitted pursuant to those rules and regulations. Certain prior period amounts have been reclassified to conform to the current period presentation. In management’s opinion, the interim financial statements reflect all adjustments that are necessary for a fair presentation of the results for the interim periods presented. All adjustments made were normal recurring accruals. Results of operations for the interim periods presented herein are not necessarily indicative of results of operations for a full year. These financial statements should be read in conjunction with the consolidated financial statements and the notes thereto contained in our Annual Report on Form 10-K for the year ended December 31, 2022 filed with the SEC.
2. Significant Accounting Policies
Note 1 to the Consolidated Financial Statements included in Part II, Item 8, of our Annual Report on Form 10-K for the year ended December 31, 2022 describes the significant accounting policies and methods used in preparation of the Condensed Consolidated Financial Statements in this Quarterly Report on Form 10-Q.
During the three months ended September 30, 2023, we purchased a short-term investment, which is included in the “Prepaid expenses and other current assets” financial statement line item on the Condensed Consolidated Balance Sheets. The s hort-term investment represents an investment in a certificate of deposit with an original maturity of less than one year. We classified the short-term investment as held-to-maturity in accordance with Accounting Standards Codification Topic 320, Investments - Debt and Equity Securities. Short-term investments classified as held-to-maturity are financial instruments the Company has the intent and ability to hold until maturity and are reported net of amortized cost. Any interest earned on the short-term investment is recorded in “Interest income and other” on the Condensed Consolidated Statements of Comprehensive Income.
3. Earnings per Common Share
Basic earnings per common share is calculated by dividing net income by the weighted average number of common shares outstanding during the period. Diluted earnings per common share adjusts basic earnings per common share for the effects of potentially dilutive common shares. Potentially dilutive common shares include the dilutive effects of shares issuable under our equity compensation plans, including stock options and share-based awards (restricted share awards, restricted stock units and performance stock units), each using the treasury stock method.
We use the if-converted method for calculating the potential dilutive effect of the conversion feature of the principal amount of our 2.0% convertible senior notes due 2023 (“2023 Convertible Notes”) on earnings per common share. The conversion feature had a dilutive impact on earnings per common share for the three and nine months ended September 30, 2023 and 2022, as the average market price per share of our common stock for the periods exceeded the conversion price of $101.38 per share. On August 17, 2023, we issued a total of 1,460,740 shares of our common stock to holders in connection with the conversion of their 2023 Convertible Notes at maturity. As of September 30, 2023, there were no 2023 Convertible Notes outstanding. See Note 8, “Debt” for additional information about the 2023 Convertible Notes.
8

| Three Months Ended September 30, |  | Nine Months Ended September 30,
| 2023 |  | 2022 |  | 2023 |  | 2022
Numerator — basic and diluted |  |  |  |  |  |  |
Net income | $ | 83,317 |  |  | $ | 77,267 |  |  | $ | 193,259 |  |  | $ | 188,016 |
Denominator |  |  |  |  |  |  |
Weighted average number of common shares outstanding — basic | 34,128 |  |  | 33,812 |  |  | 33,599 |  |  | 33,741 |
Effect of dilutive share-based awards | 515 |  |  | 545 |  |  | 547 |  |  | 607 |
Effect of dilutive stock options | 285 |  |  | 322 |  |  | 296 |  |  | 330 |
Effect of dilutive convertible notes | 728 |  |  | 1,239 |  |  | 1,157 |  |  | 1,147 |
Weighted average number of common shares outstanding — diluted | 35,656 |  |  | 35,918 |  |  | 35,599 |  |  | 35,825 |
Earnings per common share — basic | $ | 2.44 |  |  | $ | 2.29 |  |  | $ | 5.75 |  |  | $ | 5.57 |
Earnings per common share — diluted | $ | 2.34 |  |  | $ | 2.15 |  |  | $ | 5.43 |  |  | $ | 5.25 |
Antidilutive stock options and share-based awards | 2 |  |  | — |  |  | 5 |  |  | 10 |

4. Revenues
We generate the majority of our revenues by providing consulting services to our clients. Revenues are recognized when we satisfy a performance obligation by transferring services promised in a contract to a customer and in an amount that reflects the consideration that we expect to receive in exchange for those services. Performance obligations in our contracts represent distinct or separate services that we provide to our customers. If, at the outset of an arrangement, we determine that a contract with enforceable rights and obligations does not exist, revenues are deferred until all criteria for an enforceable contract are met.
Revenues recognized during the current period may include revenues from performance obligations satisfied or partially satisfied in previous periods. This primarily occurs when the estimated transaction price has changed based on our current probability assessment over whether the agreed-upon outcome for our performance-based and contingent arrangements will be achieved. The aggregate amount of revenues recognized related to a change in the transaction price in the current period, which related to performance obligations satisfied or partially satisfied in a prior period, was $10.4 million and $6.6 million for the three and nine months ended September 30, 2023, respectively, and immaterial and $12.5 million for the three and nine months ended September 30, 2022, respectively.
Unfulfilled performance obligations primarily consist of fees not yet recognized on certain fixed-fee arrangements and performance-based and contingent arrangements. As of September 30, 2023 and December 31, 2022, the aggregate amount of the remaining contract transaction price allocated to unfulfilled performance obligations was $12.1 million and $3.6 million, respectively. We expect to recognize the majority of the related revenues over the next 24 months. We elected to utilize the optional exemption to exclude from this disclosure fixed-fee and performance-based and contingent arrangements with an original expected duration of one year or less and to exclude our time and expense arrangements for which revenues are recognized using the right-to-invoice practical expedient.
Contract assets are defined as assets for which we have recorded revenues but are not yet entitled to receive our fees because certain events, such as completion of the measurement period or client approval, must occur. The contract asset balance was immaterial as of September 30, 2023 and December 31, 2022.
Contract liabilities are defined as liabilities incurred when we have received consideration but have not yet performed the agreed-upon services. This may occur when clients pay fees before work begins. The contract liability balance was immaterial as of September 30, 2023 and December 31, 2022.
9

5. Accounts Receivable and Allowance for Expected Credit Losses
The following table summarizes the components of “Accounts receivable, net” as presented on the Condensed Consolidated Balance Sheets:

| September 30, 2023 |  | December 31, 2022
Accounts receivable: |  |  |
Billed receivables | $ | 771,661 |  |  | $ | 633,055 |
Unbilled receivables | 495,270 |  |  | 308,873 |
Allowance for expected credit losses | (59,915) |  |  | (45,775) |
Accounts receivable, net | $ | 1,207,016 |  |  | $ | 896,153 |

The following table summarizes the total provision for expected credit losses and write-offs:

| Three Months Ended September 30, |  | Nine Months Ended September 30,
| 2023 |  | 2022 |  | 2023 |  | 2022
Provision for expected credit losses | $ | 10,159 |  |  | $ | 4,348 |  |  | $ | 21,347 |  |  | $ | 13,101 |
Write-offs | $ | 1,974 |  |  | $ | 3,877 |  |  | $ | 11,527 |  |  | $ | 9,917 |

Our provision for expected credit losses includes recoveries, direct write-offs and charges to other accounts. Billed accounts receivables are written off when the potential for recovery is considered remote.
6. Goodwill and Intangible Assets
Goodwill
The table below summarizes the changes in the carrying amount of goodwill by reportable segment:

| Corporate Finance & Restructuring (1) |  | Forensic and Litigation Consulting (1) |  | Economic Consulting (1) |  | Technology (1) |  | Strategic Communications (2) |  | Total
Balance at December 31, 2022 | $ | 516,500 |  |  | $ | 234,872 |  |  | $ | 268,055 |  |  | $ | 96,727 |  |  | $ | 111,439 |  |  | $ | 1,227,593 |
Foreign currency translation adjustment and other | (2,523) |  |  | 309 |  |  | 44 |  |  | 18 |  |  | 915 |  |  | (1,237) |
Intersegment transfers in/(out) (3) | 23,086 |  |  | (23,086) |  |  | — |  |  | — |  |  | — |  |  | — |
Balance at September 30, 2023 | $ | 537,063 |  |  | $ | 212,095 |  |  | $ | 268,099 |  |  | $ | 96,745 |  |  | $ | 112,354 |  |  | $ | 1,226,356 |

(1) There were no accumulated impairment losses for the Corporate Finance & Restructuring (“Corporate Finance”), Forensic and Litigation Consulting (“FLC”), Economic Consulting or Technology segments as of September 30, 2023 and December 31, 2022.
(2) Amounts for our Strategic Communications segment include gross carrying values of $306.5 million and $305.6 million as of September 30, 2023 and December 31, 2022, respectively, and accumulated impairment losses of $194.1 million as of September 30, 2023 and December 31, 2022.
(3) Includes the allocation of goodwill relating to the reclassification of the portion of the Company’s health solutions practice previously within our FLC segment, which focuses on business transformation services in the healthcare and life sciences sector, to our business transformation & strategy practice within our Corporate Finance segment. See Note 13, “Segment Reporting,” for information on this segment reclassification.
10

Intangible Assets
Intangible assets were as follows:

|  | September 30, 2023 |  | December 31, 2022
|  | Gross Carrying Amount |  | Accumulated Amortization |  | Net Carrying Amount |  | Gross Carrying Amount |  | Accumulated Amortization |  | Net Carrying Amount
Amortizing intangible assets |  |  |  |  |  |  |  |  |  |  |  |
Customer relationships |  | $ | 26,560 |  |  | $ | 15,555 |  |  | $ | 11,005 |  |  | $ | 78,223 |  |  | $ | 63,810 |  |  | $ | 14,413 |
Trademarks |  | 9,312 |  |  | 6,455 |  |  | 2,857 |  |  | 10,950 |  |  | 5,554 |  |  | 5,396 |
Acquired software and other |  | 815 |  |  | 544 |  |  | 271 |  |  | 846 |  |  | 241 |  |  | 605 |
|  | 36,687 |  |  | 22,554 |  |  | 14,133 |  |  | 90,019 |  |  | 69,605 |  |  | 20,414 |
Non-amortizing intangible assets |  |  |  |  |  |  |  |  |  |  |  |
Trademarks |  | 5,100 |  |  | — |  |  | 5,100 |  |  | 5,100 |  |  | — |  |  | 5,100 |
Total |  | $ | 41,787 |  |  | $ | 22,554 |  |  | $ | 19,233 |  |  | $ | 95,119 |  |  | $ | 69,605 |  |  | $ | 25,514 |

Intangible assets with finite lives are amortized over their estimated useful lives. We recorded amortization expense of $1.3 million and $4.9 million during the three and nine months ended September 30, 2023, respectively, and $2.3 million and $7.3 million for the three and nine months ended September 30, 2022, respectively.
We estimate our future amortization expense for our intangible assets with finite lives to be as follows:

Year |  | As of September 30, 2023 (1)
2023 (remaining) |  | $ | 1,202 |
2024 |  | 3,517 |
2025 |  | 2,856 |
2026 |  | 1,734 |
2027 |  | 1,664 |
Thereafter |  | 3,160 |
|  | $ | 14,133 |

(1)Actual amortization expense to be reported in future periods could differ from these estimates as a result of new intangible asset acquisitions, impairments, changes in useful lives, or other relevant factors or changes.
11

7. Financial Instruments
The following tables present the carrying amounts and estimated fair values of our financial instruments by hierarchy level as of September 30, 2023 and December 31, 2022:

| September 30, 2023
|  |  | Hierarchy Level (Fair Value)
| Carrying Amount |  | Level 1 |  | Level 2 |  | Level 3
Liabilities |  |  |  |  |  |  |
Acquisition-related contingent consideration (1) | $ | 13,017 |  |  | $ | — |  |  | $ | — |  |  | $ | 13,017 |
Total | $ | 13,017 |  |  | $ | — |  |  | $ | — |  |  | $ | 13,017 |

| December 31, 2022
|  |  | Hierarchy Level (Fair Value)
| Carrying Amount |  | Level 1 |  | Level 2 |  | Level 3
Liabilities |  |  |  |  |  |  |
Acquisition-related contingent consideration (1) | $ | 14,988 |  |  | $ | — |  |  | $ | — |  |  | $ | 14,988 |
2023 Convertible Notes (2) | 315,172 |  |  | — |  |  | 509,682 |  |  | — |
Total | $ | 330,160 |  |  | $ | — |  |  | $ | 509,682 |  |  | $ | 14,988 |

(1)The short-term portion is included in “Accounts payable, accrued expenses and other” and the long-term portion is included in “Other liabilities” on the Condensed Consolidated Balance Sheets.
(2)The carrying amount includes unamortized deferred debt issuance costs.
The fair values of financial instruments not included in the tables above are estimated to be equal to their carrying values as of September 30, 2023 and December 31, 2022.
We estimated the fair value of our 2023 Convertible Notes based on their last actively traded prices. The fair value of our 2023 Convertible Notes was classified within Level 2 of the fair value hierarchy as of December 31, 2022 because it was traded in less active markets. As of September 30, 2023, no 2023 Convertible Notes remain outstanding.
We estimate the fair value of acquisition-related contingent consideration using either a probability-weighted discounted cash flow model or a Monte Carlo pricing model. These fair value estimates represent Level 3 measurements as they are based on significant inputs not observed in the market and reflect our own assumptions. Significant increases (or decreases) in these unobservable inputs in isolation would result in significantly lower (or higher) fair values. We reassess the fair value of our acquisition-related contingent consideration at each reporting period based on additional information as it becomes available.
12

The change in our liability for our Level 3 financial instruments is as follows:

| Contingent Consideration
Balance at December 31, 2022 | $ | 14,988 |
Accretion expense (1) | $ | 1,284 |
Payments | (3,430) |
Foreign currency translation adjustment (2) | 238 |
Balance at March 31, 2023 | $ | 13,080 |
Accretion expense (1) | 2,259 |
Payments | (2,423) |
Foreign currency translation adjustment (2) | 67 |
Balance at June 30, 2023 | $ | 12,983 |
Accretion expense (1) | 720 |
Payments | (500) |
Foreign currency translation adjustment (2) | (186) |
Balance at September 30, 2023 | $ | 13,017 |

| Contingent Consideration
Balance at December 31, 2021 | $ | 15,110 |
Additions | $ | 5,370 |
Accretion expense (1) | (979) |
Payments | (4,430) |
Foreign currency translation adjustment (2) | (115) |
Balance at March 31, 2022 | $ | 14,956 |
Accretion expense (1) | 1,112 |
Payments | (2,240) |
Foreign currency translation adjustment (2) | (465) |
Balance at June 30, 2022 | $ | 13,363 |
Accretion expense (1) | 730 |
Payments | (1,000) |
Foreign currency translation adjustment and other (2) | (246) |
Balance at September 30, 2022 | $ | 12,847 |

(1)Accretion expense is included in SG&A expenses on the Condensed Consolidated Statements of Comprehensive Income.
(2)Foreign currency translation adjustments are included in “Other comprehensive loss, net of tax” on the Condensed Consolidated Statements of Comprehensive Income.
8. Debt
The table below presents the components of the Company’s debt:

| September 30, 2023 |  | December 31, 2022
2023 Convertible Notes | $ | — |  |  | $ | 316,219 |
Credit Facility | 285,000 |  |  | — |
Total debt | 285,000 |  |  | 316,219 |
Less: deferred debt issuance costs | — |  |  | (1,047) |
Long-term debt, net (1) | $ | 285,000 |  |  | $ | 315,172 |

(1)There were no current portions of long-term debt as of September 30, 2023 and December 31, 2022.
13

2023 Convertible Notes
On August 20, 2018, we issued the 2023 Convertible Notes in an aggregate principal amount of $316.3 million. The 2023 Convertible Notes were convertible through the close of business on August 14, 2023 at a conversion rate of 9.8643 shares of our common stock per $1,000 principal amount of the 2023 Convertible Notes (equivalent to a conversion price of approximately $101.38 per share of common stock). Certain holders of the 2023 Convertible Notes elected to convert their 2023 Convertible Notes before they became unconditionally convertible on May 15, 2023, which resulted in the settlement of approximately $0.5 million aggregate principal amount of the 2023 Convertible Notes. The principal amount of the 2023 Convertible Notes of $315.8 million was settled in cash at maturity on August 15, 2023 utilizing existing cash resources, including our senior secured bank revolving credit facility (“Credit Facility”). We also issued 1,460,740 shares of FTI Consulting common stock to holders in connection with the conversion of their 2023 Convertible Notes at maturity, which represents the excess of the conversion value over the principal amount of $280.3 million. The consideration related to the conversion premium issued to the holders who elected to convert their 2023 Convertible Notes before they became unconditionally convertible on May 15, 2023 was immaterial. As of September 30, 2023, no 2023 Convertible Notes remain outstanding.
Interest on the 2023 Convertible Notes was at a fixed rate of 2.0% per year, payable semiannually in arrears on February 15 and August 15 of each year. Contractual interest expense for the 2023 Convertible Notes was $0.8 million and $4.0 million for the three and nine months ended September 30, 2023, respectively, and $1.6 million and $4.7 million for the three and nine months ended September 30, 2022, respectively.
Credit Facility
In November 2022, we amended and restated our credit agreement for our Credit Facility to, among other things, (i) extend the maturity to November 21, 2027, (ii) increase the revolving line of credit limit from $550.0 million to $900.0 million, and (iii) increase the incremental facility from $150.0 million to a maximum of $300.0 million, subject to certain conditions, and incurred an additional $4.0 million of debt issuance costs. The Credit Facility is guaranteed by substantially all of our wholly owned domestic subsidiaries and is secured by a first priority security interest in substantially all of the assets of FTI Consulting and such domestic subsidiaries.
Borrowings under the Credit Facility bear interest at a rate equal to, in the case of: (i) U.S. Dollars (“USD”), at our option, Adjusted Term Secured Overnight Financing Rate (“SOFR”) or Adjusted Daily Simple SOFR, (ii) euro, Euro Interbank Offered Rate, (iii) British pound, Sterling Overnight Index Average Reference Rate, (iv) Australian dollars, Bank Bill Swap Reference Bid Rate, (v) Canadian dollars, Canadian Dollar Offered Rate, (vi) Swiss franc, Swiss Average Rate Overnight, and (vii) Japanese yen, Tokyo Interbank Offered Rate, in each case, plus an applicable margin that will fluctuate between 1.25% per annum and 2.00% per annum based upon the Company’s Consolidated Total Net Leverage Ratio (as defined in the Credit Facility) at such time or, in the case of USD borrowings, an alternative base rate plus an applicable margin that will fluctuate between 0.25% per annum and 1.00% per annum based upon the Company’s Consolidated Total Net Leverage Ratio at such time. The alternative base rate is a fluctuating rate per annum equal to the highest of (1) the federal funds rate plus the sum of 50 basis points, (2) the rate of interest in effect for such day as the prime rate announced by Bank of America, and (3) the one-month Term SOFR plus 100 basis points.
Under the Credit Facility, we are required to pay a commitment fee rate that fluctuates between 0.20% and 0.35% per annum and a letter of credit fee rate that fluctuates between 1.25% and 2.00% per annum, in each case, based upon the Company’s Consolidated Total Net Leverage Ratio.
The Company classified the borrowings under the Credit Facility as long-term debt in the accompanying Condensed Consolidated Balance Sheets, as we have the intent and unilateral ability to refinance any borrowings on a continuous basis through the maturity of the Credit Facility on November 21, 2027. As of September 30, 2023, $0.1 million o f the borrowing limit under the Credit Facility was utilized (and, therefore, unavailable) for letters of credit.
There were $3.6 million and $4.3 million of unamortized debt issuance costs related to the Credit Facility as of September 30, 2023 and December 31, 2022, respectively. These amounts are included in “Other assets” on our Condensed Consolidated Balance Sheets.
14

9. Leases
We lease office space and equipment under non-cancelable operating leases. We recognize operating lease expense on a straight-line basis over the lease term, which may include renewal or termination options that are reasonably certain of exercise. Most leases include one or more options to renew, with renewal terms that can extend the lease term up to seven years. The exercise of lease renewal options is at our sole discretion. Certain of our lease agreements include rental payments that are adjusted periodically for inflation. Our lease agreements do not contain any material residual value guarantees or material restrictive covenants.
The table below summarizes the carrying amount of our operating lease assets and liabilities:

Leases |  | Classification |  | September 30, 2023 |  | December 31, 2022
Assets |  |  |  |  |  |
Operating lease assets |  | Operating lease assets |  | $ | 202,505 |  |  | $ | 203,764 |
Total lease assets |  |  |  | $ | 202,505 |  |  | $ | 203,764 |
Liabilities |  |  |  |  |  |
Current |  |  |  |  |  |
Operating lease liabilities |  | Accounts payable, accrued expenses and other |  | $ | 33,052 |  |  | $ | 31,922 |
Noncurrent |  |  |  |  |  |
Operating lease liabilities |  | Noncurrent operating lease liabilities |  | 217,755 |  |  | 221,604 |
Total lease liabilities |  |  |  | $ | 250,807 |  |  | $ | 253,526 |

The table below summarizes total lease costs:

|  | Three Months Ended September 30, |  | Nine Months Ended September 30,
Lease Cost |  | 2023 |  | 2022 |  | 2023 |  | 2022
Operating lease costs |  | $ | 12,923 |  |  | $ | 11,874 |  |  | $ | 38,871 |  |  | $ | 36,328 |
Short-term lease costs |  | 756 |  |  | 441 |  |  | 2,156 |  |  | 1,573 |
Variable lease costs |  | 3,468 |  |  | 3,456 |  |  | 9,884 |  |  | 9,434 |
Sublease income |  | (320) |  |  | (224) |  |  | (959) |  |  | (610) |
Total lease cost, net |  | $ | 16,827 |  |  | $ | 15,547 |  |  | $ | 49,952 |  |  | $ | 46,725 |

The maturity analysis below summarizes the remaining future undiscounted cash flows for our operating leases and includes a reconciliation to operating lease liabilities reported on the Condensed Consolidated Balance Sheets:

| As of September 30, 2023
2023 (remaining) | $ | 11,313 |
2024 | 52,021 |
2025 | 43,709 |
2026 | 39,525 |
2027 | 39,207 |
Thereafter | 131,863 |
Total future lease payments | 317,638 |
Less: imputed interest | (66,831) |
Total | $ | 250,807 |

15

The table below includes cash paid for our operating lease liabilities, other non-cash information, our weighted average remaining lease term and weighted average discount rate:

|  |  | Nine Months Ended September 30,
|  |  |  |  | 2023 |  | 2022
Cash paid for amounts included in the measurement of operating lease liabilities |  |  |  |  | $ | 41,793 |  | $ | 38,297
Operating lease assets obtained in exchange for lease liabilities |  |  |  |  | $ | 26,488 |  | $ | 16,644
Weighted average remaining lease term (years) |  |  |  |  |  |  |
Operating leases |  |  |  |  | 8.0 |  | 8.5
Weighted average discount rate |  |  |  |  |  |  |
Operating leases |  |  |  |  | 5.8 | % |  | 5.5 | %

10. Commitments and Contingencies
We are subject to legal actions arising in the ordinary course of business. In management’s opinion, we believe we have adequate legal defenses and/or insurance coverage with respect to the eventuality of such actions. We are not aware of any asserted or unasserted legal proceedings or claims that we believe would have a material adverse effect on our financial condition or results of our operations.
11. Share-Based Compensation
During the nine months ended September 30, 2023, we granted 87,001 restricted share awards, 99,922 restricted stock units and 79,682 performance stock units under the FTI Consulting, Inc. 2017 Omnibus Incentive Compensation Plan, our employee equity compensation plan. Our performance stock units are presented at the maximum potential payout percentage of 150% of target shares granted. These awards are recorded as equity on the Condensed Consolidated Balance Sheets. During the nine months ended September 30, 2023, 6,340 shares of restricted stock, 2,534 restricted stock units and no stock options were forfeited prior to the completion of the applicable vesting requirements. Additionally, 13,021 performance stock units were forfeited during the nine months ended September 30, 2023, including award targets that were not achieved.
Total share-based compensation expense, net of forfeitures is detailed in the following table:

|  | Three Months Ended September 30, |  | Nine Months Ended September 30,
Income Statement Classification |  | 2023 |  | 2022 |  | 2023 |  | 2022
Direct cost of revenues |  | $ | 4,407 |  |  | $ | 3,510 |  |  | $ | 13,667 |  |  | $ | 11,456 |
Selling, general and administrative expenses |  | 3,581 |  |  | 2,227 |  |  | 12,488 |  |  | 9,450 |
Total share-based compensation expense |  | $ | 7,988 |  |  | $ | 5,737 |  |  | $ | 26,155 |  |  | $ | 20,906 |

12. Stockholders’ Equity
On June 2, 2016, our Board of Directors authorized a stock repurchase program of up to $100.0 million (the “Repurchase Program”). On each of May 18, 2017, December 1, 2017, February 21, 2019 and February 20, 2020, our Board of Directors authorized an additional $100.0 million. On each of July 28, 2020 and December 3, 2020, our Board of Directors authorized an additional $200.0 million. On December 1, 2022, our Board of Directors authorized an additional $400.0 million, increasing the Repurchase Program to an aggregate authorization of $1.3 billion. No time limit has been established for the completion of the Repurchase Program, and the Repurchase Program may be suspended, discontinued or replaced by the Board of Directors at any time without prior notice. As of September 30, 2023, we had $460.7 million available under the Repurchase Program to repurchase additional shares.
16

The following table details our stock repurchases under the Repurchase Program:

| Three Months Ended September 30, |  | Nine Months Ended September 30,
| 2023 |  | 2022 |  | 2023 |  | 2022
Shares of common stock repurchased and retired | — |  |  | 128 |  |  | 112 |  |  | 149 |
Average price paid per share | $ | — |  |  | $ | 159.87 |  |  | $ | 158.70 |  |  | $ | 157.48 |
Total cost | $ | — |  |  | $ | 20,430 |  |  | $ | 17,797 |  |  | $ | 23,528 |

As we repurchase our common shares, we reduce stated capital on our Condensed Consolidated Balance Sheets for the $0.01 of par value of the shares repurchased, with the excess purchase price over par value recorded as a reduction to additional paid-in capital. If additional paid-in capital is reduced to zero, we record the remainder of the excess purchase price over par value as a reduction of retained earnings.
Common stock outstanding was approximately 35.5 million shares and 34.0 million shares as of September 30, 2023 and December 31, 2022, respectively. Common stock outstanding includes unvested restricted stock awards, which are considered issued and outstanding under the terms of the restricted stock award agreements. The increase in common stock outstanding was primarily due to the issuance of a total of 1,460,740 shares of our common stock to holders in connection with the conversion of their 2023 Convertible Notes at maturity.
13. Segment Reporting
We manage our business in five reportable segments: Corporate Finance, FLC, Economic Consulting, Technology and Strategic Communications.
Our Corporate Finance segment focuses on the strategic, operational, financial, transactional and capital needs of our clients around the world. Our clients include companies, boards of directors, investors, private equity sponsors, lenders, and other financing sources and creditor groups, as well as other parties-in-interest. We deliver a wide range of services centered around three core offerings: Business Transformation & Strategy, Transactions and Turnaround & Restructuring.
Our FLC segment provides law firms, companies, boards of directors, government entities, private equity firms and other interested parties with a multidisciplinary and independent range of services in risk and investigations and disputes, including cybersecurity, and a focus on highly regulated industries such as our Construction & Environmental Solutions and Health Solutions services. These services are supported by our data & analytics technology-enabled solutions, which help our clients analyze large, disparate sets of data related to their business operations and support our clients during regulatory inquiries and commercial disputes. We deliver a wide range of services centered around five core offerings: Construction & Environmental Solutions, Data & Analytics, Disputes, Health Solutions and Risk and Investigations.
Our Economic Consulting segment, including subsidiary Compass Lexecon LLC, provides law firms, companies, government entities and other interested parties with analyses of complex economic issues for use in international arbitration, legal and regulatory proceedings, and strategic decision making and public policy debates around the world. We deliver a wide range of services centered around three core offerings: Antitrust & Competition Economics, Financial Economics and International Arbitration.
Our Technology segment provides companies, law firms, private equity firms and government entities with a comprehensive global portfolio of digital insights and risk management consulting services. Our professionals help organizations better address risk as the growing volume and variety of enterprise data intersects with legal, regulatory and compliance needs. We deliver a wide range of expert solutions driven by investigations, litigation, mergers & acquisitions, antitrust and competition, and compliance and risk through three core offerings: Corporate Legal Department Consulting, E-discovery Services and Expertise, and Information Governance, Privacy & Security services.
Our Strategic Communications segment develops and executes communications strategies to help management teams, boards of directors, law firms, governments and regulators manage change and mitigate risk surrounding transformational and disruptive events, including transactions, investigations, disputes, crises, regulation and legislation. We deliver a wide range of services centered around three core offerings: Corporate Reputation, Financial Communications and Public Affairs.
Effective July 1, 2023, we modified the composition of two of our reportable segments to reflect changes in how we operate our business. We transferred 127 billable professionals in our health solutions practice within our FLC segment who focus on business transformation services in the healthcare and life sciences sector to our business transformation & strategy practice within our Corporate Finance segment. This change aligns this group of professionals with the broader business transformation capabilities within the Corporate Finance segment. Eighty-three billable professionals who focus on advisory
17

and managed care services within the health solutions practice remained in the FLC segment. Prior period Corporate Finance and FLC segment information included in this Quarterly Report on Form 10-Q has been reclassified to conform to the current period presentation.
We evaluate the performance of our operating segments based on Adjusted Segment EBITDA, a GAAP financial measure. We define Adjusted Segment EBITDA as a segment’s share of consolidated operating income before depreciation, amortization of intangible assets, remeasurement of acquisition-related contingent consideration, special charges and goodwill impairment charges. We define Total Adjusted Segment EBITDA, which is a non-GAAP financial measure, as the total of Adjusted Segment EBITDA for all segments, which excludes unallocated corporate expenses. We use Adjusted Segment EBITDA as a basis to internally evaluate the financial performance of our segments because we believe it reflects current core operating performance and provides an indicator of the segment’s ability to generate cash.
The table below presents revenues and Adjusted Segment EBITDA for our reportable segments:

| Three Months Ended September 30, |  | Nine Months Ended September 30,
| 2023 |  | 2022 |  | 2023 |  | 2022
Revenues |  |  |  |  |  |  |
Corporate Finance (1) | $ | 347,560 |  |  | $ | 282,029 |  |  | $ | 981,124 |  |  | $ | 841,804 |
FLC (1) | 166,137 |  |  | 143,289 |  |  | 488,636 |  |  | 432,054 |
Economic Consulting | 193,866 |  |  | 193,183 |  |  | 565,283 |  |  | 523,201 |
Technology | 98,860 |  |  | 84,915 |  |  | 286,922 |  |  | 243,181 |
Strategic Communications | 86,838 |  |  | 72,449 |  |  | 242,593 |  |  | 214,237 |
Total revenues | $ | 893,261 |  |  | $ | 775,865 |  |  | $ | 2,564,558 |  |  | $ | 2,254,477 |
Adjusted Segment EBITDA |  |  |  |  |  |  |
Corporate Finance (1) | $ | 68,094 |  |  | $ | 53,519 |  |  | $ | 165,450 |  |  | $ | 165,683 |
FLC (1) | 21,480 |  |  | 16,175 |  |  | 68,861 |  |  | 46,464 |
Economic Consulting | 27,756 |  |  | 32,913 |  |  | 77,472 |  |  | 75,754 |
Technology | 14,873 |  |  | 13,213 |  |  | 50,326 |  |  | 34,940 |
Strategic Communications | 13,454 |  |  | 12,947 |  |  | 35,273 |  |  | 40,133 |
Total Adjusted Segment EBITDA | $ | 145,657 |  |  | $ | 128,767 |  |  | $ | 397,382 |  |  | $ | 362,974 |

(1)Effective July 1, 2023, Corporate Finance and FLC segment information for the prior periods has been recast in this Quarterly Report on Form 10-Q to include the reclassification of the portion of the Company’s health solutions practice in the FLC segment to our business transformation & strategy practice within our Corporate Finance segment.
The table below reconciles net income to Total Adjusted Segment EBITDA:

| Three Months Ended September 30, |  | Nine Months Ended September 30,
| 2023 |  | 2022 |  | 2023 |  | 2022
Net income | $ | 83,317 |  |  | $ | 77,267 |  |  | $ | 193,259 |  |  | $ | 188,016 |
Add back: |  |  |  |  |  |  |
Income tax provision | 24,385 |  |  | 15,836 |  |  | 62,067 |  |  | 46,156 |
Interest income and other | (5,147) |  |  | (7,771) |  |  | (3,221) |  |  | (10,418) |
Interest expense | 4,474 |  |  | 2,378 |  |  | 10,435 |  |  | 7,468 |
Unallocated corporate expenses | 27,589 |  |  | 30,470 |  |  | 101,349 |  |  | 99,524 |
Segment depreciation expense | 9,699 |  |  | 8,273 |  |  | 28,554 |  |  | 24,909 |
Amortization of intangible assets | 1,340 |  |  | 2,314 |  |  | 4,939 |  |  | 7,319 |
Total Adjusted Segment EBITDA | $ | 145,657 |  |  | $ | 128,767 |  |  | $ | 397,382 |  |  | $ | 362,974 |

18

Item 2. | Management’s Discussion and Analysis of Financial Condition and Results of Operations

The following is a discussion and analysis of our consolidated financial condition, results of operations, and liquidity and capital resources for the three and nine months ended September 30, 2023 and 2022, and significant factors that could affect our prospective financial condition and results of operations. This discussion should be read in conjunction with the accompanying unaudited condensed consolidated financial statements and related notes and with our Annual Report on Form 10-K for the year ended December 31, 2022 filed with the United States (“U.S.”) Securities and Exchange Commission (“SEC”). In addition to historical information, the following discussion includes forward-looking statements based on current expectations that involve risks, uncertainties and assumptions, such as our plans, objectives, expectations and intentions. Although we believe that the expectations reflected in the forward-looking statements contained herein are reasonable, these expectations or any of the forward-looking statements could prove to be incorrect, and actual results could differ materially from those projected or assumed in the forward-looking statements.
BUSINESS OVERVIEW
FTI Consulting, Inc., including its consolidated subsidiaries (collectively, the “Company,” “we,” “our” or “FTI Consulting”), is a global business advisory firm dedicated to helping organizations manage change, mitigate risk and resolve disputes: financial, legal, operational, political & regulatory, reputational and transactional. Individually, each of our segments and practices is staffed with experts recognized for the depth of their knowledge and a track record of making an impact. Collectively, FTI Consulting offers a comprehensive suite of services designed to assist clients across the business cycle, from proactive risk management to rapid response to unexpected events and dynamic environments.
We report financial results for the following five reportable segments:
Our Corporate Finance & Restructuring (“Corporate Finance”) segment focuses on the strategic, operational, financial, transactional and capital needs of our clients around the world. Our clients include companies, boards of directors, investors, private equity sponsors, lenders, and other financing sources and creditor groups, as well as other parties-in-interest. We deliver a wide range of services centered around three core offerings: Business Transformation & Strategy, Transactions and Turnaround & Restructuring.
Our Forensic and Litigation Consulting (“FLC”) segment provides law firms, companies, boards of directors, government entities, private equity firms and other interested parties with a multidisciplinary and independent range of services in risk and investigations and disputes, including cybersecurity, and a focus on highly regulated industries such as our Construction & Environmental Solutions and Health Solutions services. These services are supported by our data & analytics technology-enabled solutions, which help our clients analyze large, disparate sets of data related to their business operations and support our clients during regulatory inquiries and commercial disputes. We deliver a wide range of services centered around five core offerings: Construction & Environmental Solutions, Data & Analytics, Disputes, Health Solutions and Risk and Investigations.
Our Economic Consulting segment, including subsidiary Compass Lexecon LLC, provides law firms, companies, government entities and other interested parties with analyses of complex economic issues for use in international arbitration, legal and regulatory proceedings, and strategic decision making and public policy debates around the world. We deliver a wide range of services centered around three core offerings: Antitrust & Competition Economics, Financial Economics and International Arbitration.
Our Technology segment provides companies, law firms, private equity firms and government entities with a comprehensive global portfolio of digital insights and risk management consulting services. Our professionals help organizations better address risk as the growing volume and variety of enterprise data intersects with legal, regulatory and compliance needs. We deliver a wide range of expert solutions driven by investigations, litigation, mergers & acquisitions (“M&A”), antitrust and competition, and compliance and risk through three core offerings: Corporate Legal Department Consulting, E-discovery Services and Expertise, and Information Governance, Privacy & Security services.
Our Strategic Communications segment develops and executes communications strategies to help management teams, boards of directors, law firms, governments and regulators manage change and mitigate risk surrounding transformational and disruptive events, including transactions, investigations, disputes, crises, regulation and legislation. We deliver a wide range of services centered around three core offerings: Corporate Reputation, Financial Communications and Public Affairs.
Effective July 1, 2023, we modified the composition of two of our reportable segments to reflect changes in how we operate our business. We transferred 127 billable professionals in our health solutions practice within our FLC segment who focus on business transformation services in the healthcare and life sciences sector to our business transformation & strategy practice within our Corporate Finance segment. This change aligns this group of professionals with the broader business
19

transformation capabilities within the Corporate Finance segment. Eighty-three billable professionals who focus on advisory and managed care services within the health solutions practice remained in the FLC segment. Prior period Corporate Finance and FLC segment information included in this Quarterly Report on Form 10-Q has been reclassified to conform to the current period presentation.
We derive substantially all of our revenues from providing professional services to both U.S. and global clients. Most of our services are rendered under time and expense contract arrangements, which require the client to pay us based on the number of hours worked at contractually agreed-upon rates. Under this arrangement, we typically bill our clients for reimbursable expenses, including those relating to travel, out-of-pocket expenses, outside consultants and other outside service costs. Certain contracts are rendered under fixed-fee arrangements, which require the client to pay a fixed fee in exchange for a predetermined set of professional services. Fixed-fee arrangements may require certain clients to pay us a recurring retainer. Our contract arrangements may also contain success fees or performance-based arrangements in which our fees are based on the attainment of contractually defined objectives with our client. This type of success fee may supplement a time and expense or fixed-fee arrangement. Success fee revenues may cause variations in our revenues and operating results due to the timing of when achieving the performance-based criteria becomes probable. Seasonal factors, such as the timing of our employees’ and clients’ vacations and holidays, may impact the timing of our revenues across our segments.
In our Technology segment, certain clients are billed based on the amount of data storage used or the volume of information processed. Unit-based revenues are defined as revenues billed on a per item, per page or another unit-based method and include revenues from data processing and hosting. Unit-based revenues include revenues associated with the software products that are made available to customers via a web browser (“on-demand”). On-demand revenues are charged on a unit or monthly basis and include, but are not limited to, processing and review related functions.
Our financial results are primarily driven by:
•the number, size and type of engagements we secure;
•the rate per hour or fixed charges we charge our clients for services;
•the utilization rates of the revenue-generating professionals we employ;
•the timing of revenue recognition related to revenues subject to certain performance-based contingencies;
•the number of revenue-generating professionals;
•the types of assignments we are working on at different times;
•the length of the billing and collection cycles; and
•the geographic locations of our clients or locations in which services are rendered.
We define acquisition growth as revenues of acquired companies in the first 12 months following the effective date of an acquisition. When significant, we identify the impact of acquisition-related revenue growth.
When significant, we identify the estimated impact of foreign currency (“FX”) driven by our businesses with functional currencies other than the U.S. dollar (“USD”). The estimated impact of FX on the period-to-period performance results is calculated as the difference between the prior period results, multiplied by the average FX exchange rates to USD in the current period and the prior period results, multiplied by the average FX exchange rates to USD in the prior period.
Non-GAAP Financial Measures
In the accompanying analysis of financial information, we sometimes use information derived from consolidated and segment financial information that may not be presented in our financial statements or prepared in accordance with generally accepted accounting principles in the U.S. (“GAAP”). Certain of these financial measures are considered not in conformity with GAAP (“non-GAAP financial measures”) under the SEC rules. Specifically, we have referred to the following non-GAAP financial measures:
•Total Segment Operating Income
•Adjusted EBITDA
•Total Adjusted Segment EBITDA
20

•Adjusted EBITDA Margin
•Adjusted Net Income
•Adjusted Earnings per Diluted Share
•Free Cash Flow
We have included the definitions of Segment Operating Income and Adjusted Segment EBITDA, which are GAAP financial measures, below in order to more fully define the components of certain non-GAAP financial measures in the accompanying analysis of financial information. As described in Note 13, “Segment Reporting” in Part I, Item 1, of this Quarterly Report on Form 10-Q, we evaluate the performance of our operating segments based on Adjusted Segment EBITDA, and Segment Operating Income is a component of the definition of Adjusted Segment EBITDA.
We define Segment Operating Income as a segment’s share of consolidated operating income. We define Total Segment Operating Income, which is a non-GAAP financial measure, as the total of Segment Operating Income for all segments, which excludes unallocated corporate expenses. We use Segment Operating Income for the purpose of calculating Adjusted Segment EBITDA. We define Adjusted Segment EBITDA as a segment’s share of consolidated operating income before depreciation, amortization of intangible assets, remeasurement of acquisition-related contingent consideration, special charges and goodwill impairment charges. We use Adjusted Segment EBITDA as a basis to internally evaluate the financial performance of our segments because we believe it reflects current core operating performance and provides an indicator of the segment’s ability to generate cash.
We define Total Adjusted Segment EBITDA, which is a non-GAAP financial measure, as the total of Adjusted Segment EBITDA for all segments, which excludes unallocated corporate expenses. We define Adjusted EBITDA, which is a non-GAAP financial measure, as consolidated net income before income tax provision, other non-operating income (expense), depreciation, amortization of intangible assets, remeasurement of acquisition-related contingent consideration, special charges, goodwill impairment charges, gain or loss on sale of a business and losses on early extinguishment of debt. We believe that these non-GAAP financial measures, when considered together with our GAAP financial results and GAAP financial measures, provide management and investors with a more complete understanding of our operating results, including underlying trends. In addition, EBITDA is a common alternative measure of operating performance used by many of our competitors. It is used by investors, financial analysts, rating agencies and others to value and compare the financial performance of companies in our industry. Therefore, we also believe that these non-GAAP financial measures, considered along with corresponding GAAP financial measures, provide management and investors with additional information for comparison of our operating results with the operating results of other companies. We define Adjusted EBITDA Margin, which is a non-GAAP financial measure, as Adjusted EBITDA as a percentage of total revenues.
We define Adjusted Net Income and Adjusted Earnings per Diluted Share (“Adjusted EPS”), which are non-GAAP financial measures, as net income and earnings per diluted share (“EPS”), respectively, excluding the impact of remeasurement of acquisition-related contingent consideration, special charges, goodwill impairment charges, losses on early extinguishment of debt, non-cash interest expense on convertible notes and the gain or loss on sale of a business. We use Adjusted Net Income for the purpose of calculating Adjusted EPS. Management uses Adjusted EPS to assess total Company operating performance on a consistent basis. We believe that these non-GAAP financial measures, when considered together with our GAAP financial results and GAAP financial measures, provide management and investors with an additional understanding of our business operating results, including underlying trends.
We define Free Cash Flow, which is a non-GAAP financial measure, as net cash provided by (used in) operating activities less cash payments for purchases of property and equipment. We believe this non-GAAP financial measure, when considered together with our GAAP financial results, provides management and investors with an additional understanding of the Company’s ability to generate cash for ongoing business operations and other capital deployment.
Non-GAAP financial measures are not defined in the same manner by all companies and may not be comparable with other similarly titled measures of other companies. Non-GAAP financial measures should be considered in addition to, but not as a substitute for or superior to, the information contained in our Condensed Consolidated Statements of Comprehensive Income and Condensed Consolidated Statements of Cash Flows. Reconciliations of these non-GAAP financial measures to the most directly comparable GAAP financial measures are included elsewhere in this report.
21

EXECUTIVE HIGHLIGHTS

| Three Months Ended September 30, |  | Nine Months Ended September 30,
| 2023 |  | 2022 |  | 2023 |  | 2022
| (dollar amounts in thousands, except per share data) |  | (dollar amounts in thousands, except per share data)
Revenues | $ | 893,261 |  |  | $ | 775,865 |  |  | $ | 2,564,558 |  |  | $ | 2,254,477 |
Net income | $ | 83,317 |  |  | $ | 77,267 |  |  | $ | 193,259 |  |  | $ | 188,016 |
Adjusted EBITDA | $ | 118,748 |  |  | $ | 98,974 |  |  | $ | 297,405 |  |  | $ | 265,587 |
Earnings per common share — diluted | $ | 2.34 |  |  | $ | 2.15 |  |  | $ | 5.43 |  |  | $ | 5.25 |
Adjusted earnings per common share — diluted | $ | 2.34 |  |  | $ | 2.15 |  |  | $ | 5.43 |  |  | $ | 5.25 |
Net cash provided by (used in) operating activities | $ | 106,675 |  |  | $ | 128,292 |  |  | $ | (158,525) |  |  | $ | (40,439) |
Total number of employees | 8,089 |  |  | 7,518 |  |  | 8,089 |  |  | 7,518 |

Third Quarter 2023 Executive Highlights
Revenues
Revenues for the three months ended September 30, 2023 increased $117.4 million, or 15.1%, to $893.3 million, which included a 1.5% estimated positive impact from FX. Excluding the estimated impact from FX, revenues increased $105.4 million, or 13.6%, compared to the three months ended September 30, 2022, primarily due to higher demand in our Corporate Finance, FLC, Strategic Communications and Technology segments.
Net income
Net income for the three months ended September 30, 2023 increased $6.1 million, or 7.8%, to $83.3 million, compared to the three months ended September 30, 2022. The increase in net income was primarily due to higher revenues, which was partially offset by an increase in direct compensation expenses, which included the impact of a 7.8% increase in billable headcount, higher selling, general and administrative (“SG&A”) expenses, which included the impact of a 6.9% increase in non-billable headcount, a higher effective tax rate and a lower FX remeasurement gain compared to the same quarter in the prior year.
Adjusted EBITDA
Adjusted EBITDA for the three months ended September 30, 2023 increased $19.8 million, or 20.0%, to $118.7 million, compared to the three months ended September 30, 2022. Adjusted EBITDA Margin of 13.3% for the three months ended September 30, 2023 compared to 12.8% for the three months ended September 30, 2022. The increase in Adjusted EBITDA was due to higher revenues, which was partially offset by higher direct compensation expenses, which included the impact of a 7.8% increase in billable headcount, and an increase in SG&A expenses, which included the impact of a 6.9% increase in non-billable headcount, compared to the same quarter in the prior year.
EPS and Adjusted EPS
EPS for the three months ended September 30, 2023 increased $0.19 to $2.34 compared to $2.15 for the three months ended September 30, 2022. The increase in EPS was primarily due to higher net income as described above.
Adjusted EPS was equal to EPS for the three months ended September 30, 2023 and 2022, respectively.
Liquidity and Capital Allocation
Net cash provided by operating activities for the three months ended September 30, 2023 decreased $21.6 million to $106.7 million, compared to $128.3 million for the three months ended September 30, 2022. The decrease in net cash provided by operating activities was primarily due to cash collections not keeping pace with the increase in revenues and not sufficiently offsetting the increase in salaries and other employee cash compensation, largely related to headcount growth, and higher operating expenses. Da ys sales outstanding (“DSO”) was 114 days at September 30, 2023 compared to 106 days at September 30, 2022. The increase in DSO was primarily due to cash collections that have not kept pace with higher revenues.
Free Cash Flow was an inflow of $92.5 million and $115.0 million for the three months ended September 30, 2023 and 2022, respectively. The decrease in Free Cash Flow for the three months ended September 30, 2023 was primarily due to lower net cash provided by operating activities, as described above.
22

Headcount
The following table includes the net headcount additions (reductions) by segment and in total for the nine months ended September 30, 2023.

| Billable Headcount |  |  |  |
|  | Corporate Finance (1) |  | FLC (1) |  | Economic Consulting |  | Technology |  | Strategic Communications |  | Total |  | Non-Billable Headcount |  | Total Headcount
December 31, 2022 |  | 2,100 |  | 1,430 |  | 1,007 |  | 556 |  | 970 |  | 6,063 |  | 1,572 |  | 7,635
Additions (reductions), net |  | 52 |  | (3) |  | 24 |  | 25 |  | 25 |  | 123 |  | 36 |  | 159
March 31, 2023 |  | 2,152 |  | 1,427 |  | 1,031 |  | 581 |  | 995 |  | 6,186 |  | 1,608 |  | 7,794
Additions (reductions), net |  | 18 |  | 14 |  | 8 |  | 8 |  | (3) |  | 45 |  | 14 |  | 59
June 30, 2023 |  | 2,170 |  | 1,441 |  | 1,039 |  | 589 |  | 992 |  | 6,231 |  | 1,622 |  | 7,853
Additions (reductions), net |  | 81 |  | 62 |  | 46 |  | 40 |  | 18 |  | 247 |  | (11) |  | 236
September 30, 2023 |  | 2,251 |  | 1,503 |  | 1,085 |  | 629 |  | 1,010 |  | 6,478 |  | 1,611 |  | 8,089
Percentage change in headcount from December 31, 2022 |  | 7.2% |  | 5.1% |  | 7.7% |  | 13.1% |  | 4.1% |  | 6.8% |  | 2.5% |  | 5.9%

(1)Effective July 1, 2023, Corporate Finance and FLC segment information for the prior periods has been recast in this Quarterly Report on Form 10-Q to include the reclassification of the portion of the Company’s health solutions practice in the FLC segment to our business transformation & strategy practice within our Corporate Finance segment.
23

CONSOLIDATED RESULTS OF OPERATIONS
Segment and Consolidated Operating Results:

| Three Months Ended September 30, |  | Nine Months Ended September 30,
| 2023 |  | 2022 |  | 2023 |  | 2022
| (in thousands, except per share data) |  | (in thousands, except per share data)
Revenues |  |  |  |  |  |  |
Corporate Finance (1) | $ | 347,560 |  |  | $ | 282,029 |  |  | $ | 981,124 |  |  | $ | 841,804 |
FLC (1) | 166,137 |  |  | 143,289 |  |  | 488,636 |  |  | 432,054 |
Economic Consulting | 193,866 |  |  | 193,183 |  |  | 565,283 |  |  | 523,201 |
Technology | 98,860 |  |  | 84,915 |  |  | 286,922 |  |  | 243,181 |
Strategic Communications | 86,838 |  |  | 72,449 |  |  | 242,593 |  |  | 214,237 |
Total revenues | $ | 893,261 |  |  | $ | 775,865 |  |  | $ | 2,564,558 |  |  | $ | 2,254,477 |
Segment operating income |  |  |  |  |  |  |
Corporate Finance (1) | $ | 64,633 |  |  | $ | 49,865 |  |  | $ | 154,724 |  |  | $ | 154,416 |
FLC (1) | 19,708 |  |  | 14,653 |  |  | 63,881 |  |  | 41,646 |
Economic Consulting | 26,293 |  |  | 31,674 |  |  | 73,017 |  |  | 72,056 |
Technology | 11,481 |  |  | 9,833 |  |  | 39,803 |  |  | 25,005 |
Strategic Communications | 12,503 |  |  | 12,155 |  |  | 32,464 |  |  | 37,623 |
Total segment operating income | 134,618 |  |  | 118,180 |  |  | 363,889 |  |  | 330,746 |
Unallocated corporate expenses | (27,589) |  |  | (30,470) |  |  | (101,349) |  |  | (99,524) |
Operating income | 107,029 |  |  | 87,710 |  |  | 262,540 |  |  | 231,222 |
Other income (expense) |  |  |  |  |  |  |
Interest income and other | 5,147 |  |  | 7,771 |  |  | 3,221 |  |  | 10,418 |
Interest expense | (4,474) |  |  | (2,378) |  |  | (10,435) |  |  | (7,468) |
| 673 |  |  | 5,393 |  |  | (7,214) |  |  | 2,950 |
Income before income tax provision | 107,702 |  |  | 93,103 |  |  | 255,326 |  |  | 234,172 |
Income tax provision | 24,385 |  |  | 15,836 |  |  | 62,067 |  |  | 46,156 |
Net income | $ | 83,317 |  |  | $ | 77,267 |  |  | $ | 193,259 |  |  | $ | 188,016 |
Earnings per common share — basic | $ | 2.44 |  |  | $ | 2.29 |  |  | $ | 5.75 |  |  | $ | 5.57 |
Earnings per common share — diluted | $ | 2.34 |  |  | $ | 2.15 |  |  | $ | 5.43 |  |  | $ | 5.25 |

(1)Effective July 1, 2023, Corporate Finance and FLC segment information for the prior periods has been recast in this Quarterly Report on Form 10-Q to include the reclassification of the portion of the Company’s health solutions practice in the FLC segment to our business transformation & strategy practice within our Corporate Finance segment.
Reconciliation of Net Income to Adjusted EBITDA:

| Three Months Ended September 30, |  | Nine Months Ended September 30,
| 2023 |  | 2022 |  | 2023 |  | 2022
| (in thousands) |  | (in thousands)
Net income | $ | 83,317 |  |  | $ | 77,267 |  |  | $ | 193,259 |  |  | $ | 188,016 |
Add back: |  |  |  |  |  |  |
Income tax provision | 24,385 |  |  | 15,836 |  |  | 62,067 |  |  | 46,156 |
Interest income and other | (5,147) |  |  | (7,771) |  |  | (3,221) |  |  | (10,418) |
Interest expense | 4,474 |  |  | 2,378 |  |  | 10,435 |  |  | 7,468 |
Depreciation and amortization | 10,379 |  |  | 8,949 |  |  | 29,926 |  |  | 27,045 |
Amortization of intangible assets | 1,340 |  |  | 2,315 |  |  | 4,939 |  |  | 7,320 |
Adjusted EBITDA | $ | 118,748 |  |  | $ | 98,974 |  |  | $ | 297,405 |  |  | $ | 265,587 |

24

Reconciliation of Net Income and EPS to Adjusted Net Income and Adjusted EPS:
Net Income and EPS were equal to Adjusted Net Income and Adjusted EPS, respectively, for the three and nine months ended September 30, 2023 and 2022.
Reconciliation of Net Cash Provided by (Used in) Operating Activities to Free Cash Flow:

| Three Months Ended September 30, |  | Nine Months Ended September 30,
| 2023 |  | 2022 |  | 2023 |  | 2022
| (in thousands) |  | (in thousands)
Net cash provided by (used in) operating activities | $ | 106,675 |  |  | $ | 128,292 |  |  | $ | (158,525) |  |  | $ | (40,439) |
Purchases of property and equipment | (14,199) |  |  | (13,316) |  |  | (43,284) |  |  | (38,951) |
Free Cash Flow | $ | 92,476 |  |  | $ | 114,976 |  |  | $ | (201,809) |  |  | $ | (79,390) |

Three Months Ended September 30, 2023 Compared with Three Months Ended September 30, 2022
Revenues and operating income
See “Segment Re sults” for an expanded discussion of revenues, gross profit and SG&A expenses.
Unallocated corporate expenses
Unallocated corporate expenses for the three months ended September 30, 2023 decreased $2.9 million, or 9.5%, to $27.6 million compared to $30.5 million for the three months ended September 30, 2022. The decrease was primarily due to lower expenses for corporate initiatives and higher infrastructure support expenses that were not previously allocated to the segments, which was partially offset by higher compensation expenses.
Interest income and other
Interest income and other, which includes FX gains and losses, decreased $2.6 million, or 33.8%, to $5.1 million for the three months ended September 30, 2023 compa red to $7.8 million for the three months ended September 30, 2022. The decline was primarily due to a $4.3 million decrease in FX gains, which was partially offset by a $1.3 million increase in interest income.
FX gains and losses, both realized and unrealized, relate to the remeasurement or settlement of monetary assets and liabilities that are denominated in a currency other than an entity’s functional currency. These monetary assets and liabilities include cash, as well as third-party and intercompany receivables and payables.
Interest expense
Interest expense increased $2.1 million, or 88.1%, to $4.5 million for the three months ended September 30, 2023 compared to $2.4 million fo r the three months ended September 30, 2022. The increase was primarily due to higher interest rates on increased borrowings under our senior secured bank revolving credit facility (“Credit Facility”) incurred in connection with the repayment at maturity of the principal amount of our 2.0% convertible senior notes due 2023 (“2023 Convertible Notes”).
Income tax provision
Our income tax provision increased $8.5 million, or 54.0%, to $24.4 million for the three months ended September 30, 2023 compared to $15.8 million for the three months ended September 30, 2022. Our effective tax rate of 22.6% for the three months ended September 30, 2023 compared to 17.0% for the three months ended September 30, 2022. The increase in the income tax provision was due to an increase in income before income tax. The tax rate for the three months ended September 30, 2022 was favorably impacted by a combined $8.3 million tax benefit from the release of a U.S. foreign tax credit valuation allowance, utilization of current year foreign tax credits and a deferred tax benefit arising from an intellectual property license agreement between a U.S. subsidiary of the Company and certain foreign subsidiaries of the Company.
Nine Months Ended September 30, 2023 Compared with Nine Months Ended September 30, 2022
Revenues and operating income
See “Segment Re sults” for an expanded discussion of revenues, gross profit and SG&A expenses.
25

Unallocated corporate expenses
Unallocated corporate expenses for the nine months ended September 30, 2023 increased $1.8 million, or 1.8%, to $101.3 million compared to $99.5 million for the nine months ended September 30, 2022. The increase was primarily due to higher compensation expenses, which was partially offset by higher infrastructure support expenses that were not previously allocated to the segments and lower expenses for corporate initiatives.
Interest income and other
Interest income and other, which includes FX gains and losses, decreased $7.2 million, or 69.1%, to $3.2 million for the nine months ended September 30, 2023 compared to $10.4 million for the nine months ended September 30, 2022. The decrease was primarily due to a $3.8 million FX loss for the nine months ended September 30, 2023 compared to a $7.9 million FX gain for the nine months ended September 30, 2022, which was partially offset by a $4.3 million increase in interest income.
Interest expense
Interest expense for the nine months ended September 30, 2023 increased $3.0 million, or 39.7%, to $10.4 million compared to $7.5 million for the nine months ended September 30, 2022. The increase was primarily due to higher interest rates on increased borrowings under our Credit Facility.
Income tax provision
Our income tax provision increased $15.9 million, or 34.5%, to $62.1 million for the nine months ended September 30, 2023 compared to $46.2 million for the nine months ended September 30, 2022. Our effective tax rate of 24.3% for the nine months ended September 30, 2023 compared to 19.7% for the nine months ended September 30, 2022. The increase in the income tax provision was due to an increase in income before income tax. The tax rate for the nine months ended September 30, 2022 was favorably impacted by a combined $8.3 million tax benefit from the release of a U.S. foreign tax credit valuation allowance, utilization of current year foreign tax credits and a deferred tax benefit arising from an intellectual property license agreement between a U.S. subsidiary of the Company and certain foreign subsidiaries of the Company.
SEGMENT RESULTS
Total Adjusted Segment EBITDA
We evaluate the performance of each of our operating segments based on Adjusted Segment EBITDA, which is a GAAP financial measure. The following table reconciles net income to Total Adjusted Segment EBITDA, a non-GAAP financial measure, for the three and nine months ended September 30, 2023 and 2022:

| Three Months Ended September 30, |  | Nine Months Ended September 30,
| 2023 |  | 2022 |  | 2023 |  | 2022
| (in thousands) |  | (in thousands)
Net income | $ | 83,317 |  |  | $ | 77,267 |  |  | $ | 193,259 |  |  | $ | 188,016 |
Add back: |  |  |  |  |  |  |
Income tax provision | 24,385 |  |  | 15,836 |  |  | 62,067 |  |  | 46,156 |
Interest income and other | (5,147) |  |  | (7,771) |  |  | (3,221) |  |  | (10,418) |
Interest expense | 4,474 |  |  | 2,378 |  |  | 10,435 |  |  | 7,468 |
Unallocated corporate expenses | 27,589 |  |  | 30,470 |  |  | 101,349 |  |  | 99,524 |
Total segment operating income | 134,618 |  |  | 118,180 |  |  | 363,889 |  |  | 330,746 |
Add back: |  |  |  |  |  |  |
Segment depreciation expense | 9,699 |  |  | 8,273 |  |  | 28,554 |  |  | 24,909 |
Amortization of intangible assets | 1,340 |  |  | 2,314 |  |  | 4,939 |  |  | 7,319 |
Total Adjusted Segment EBITDA | $ | 145,657 |  |  | $ | 128,767 |  |  | $ | 397,382 |  |  | $ | 362,974 |

26

Other Segment Operating Data

| Three Months Ended September 30, |  | Nine Months Ended September 30,
| 2023 |  | 2022 |  | 2023 |  | 2022
Number of revenue-generating professionals (at period end): |  |  |  |  |  |  |
Corporate Finance (4) | 2,251 |  |  | 2,050 |  |  | 2,251 |  |  | 2,050 |
FLC (4) | 1,503 |  |  | 1,464 |  |  | 1,503 |  |  | 1,464 |
Economic Consulting | 1,085 |  |  | 998 |  |  | 1,085 |  |  | 998 |
Technology (1) | 629 |  |  | 548 |  |  | 629 |  |  | 548 |
Strategic Communications | 1,010 |  |  | 951 |  |  | 1,010 |  |  | 951 |
Total revenue-generating professionals | 6,478 |  |  | 6,011 |  |  | 6,478 |  |  | 6,011 |
Utilization rates of billable professionals: (2) |  |  |  |  |  |  |
Corporate Finance (4) | 60 | % |  | 61 | % |  | 59 | % |  | 62 | %
FLC (4) | 57 | % |  | 53 | % |  | 58 | % |  | 55 | %
Economic Consulting | 65 | % |  | 67 | % |  | 67 | % |  | 70 | %
Average billable rate per hour: (3) |  |  |  |  |  |  |
Corporate Finance (4) | $ | 514 |  |  | $ | 445 |  |  | $ | 492 |  |  | $ | 448 |
FLC (4) | $ | 388 |  |  | $ | 360 |  |  | $ | 384 |  |  | $ | 355 |
Economic Consulting | $ | 559 |  |  | $ | 579 |  |  | $ | 533 |  |  | $ | 506 |

(1)The number of revenue-generating professionals for the Technology segment excludes as-needed professionals, who we employ based on demand for the segment’s services. We employed an average of 792 as-needed employees during the three months ended September 30, 2023 compared with 634 as-needed employees during the three months ended September 30, 2022.
(2)We calculate the utilization rate for our billable professionals by dividing the number of hours that all of our billable professionals worked on client assignments during a period by the total available working hours for all of our billable professionals during the same period. Available hours are determined by the standard hours worked by each employee, adjusted for part-time hours, U.S. standard work weeks and local country holidays. Available working hours include vacation and professional training days, but exclude holidays. Utilization rates are presented for our segments that primarily bill clients on an hourly basis. We have not presented utilization rates for our Technology and Strategic Communications segments as most of the revenues of these segments are not generated on an hourly basis.
(3)For engagements where revenues are based on number of hours worked by our billable professionals and fixed-fee arrangements, average billable rate per hour is calculated by dividing revenues (excluding revenues from success fees, pass-through revenues and outside consultants) for a period by the number of hours worked on client assignments during the same period. We have not presented average billable rates per hour for our Technology and Strategic Communications segments as most of the revenues of these segments are not based on billable hours.
(4)Effective July 1, 2023, Corporate Finance and FLC segment information for the prior periods has been recast in this Quarterly Report on Form 10-Q to include the reclassification of the portion of the Company’s health solutions practice in the FLC segment to our business transformation & strategy practice within our Corporate Finance segment.
27

CORPORATE FINANCE & RESTRUCTURING

| Three Months Ended September 30, |  | Nine Months Ended September 30,
| 2023 |  | 2022 (3) |  | 2023 |  | 2022 (3)
| (dollars in thousands, except rate per hour) |  | (dollars in thousands, except rate per hour)
Revenues | $ | 347,560 |  |  | $ | 282,029 |  |  | $ | 981,124 |  |  | $ | 841,804 |
Percentage change in revenues from prior year | 23.2 | % |  | 9.0 | % |  | 16.6 | % |  | 14.3 | %
Operating expenses |  |  |  |  |  |  |
Direct cost of revenues | 231,500 |  |  | 188,841 |  |  | 667,498 |  |  | 557,801 |
Selling, general and administrative expenses | 50,380 |  |  | 41,414 |  |  | 154,833 |  |  | 123,551 |
Amortization of intangible assets | 1,047 |  |  | 1,909 |  |  | 4,069 |  |  | 6,036 |
| 282,927 |  |  | 232,164 |  |  | 826,400 |  |  | 687,388 |
Segment operating income | 64,633 |  |  | 49,865 |  |  | 154,724 |  |  | 154,416 |
Percentage change in segment operating income from prior year | 29.6 | % |  | -2.2 | % |  | 0.2 | % |  | 21.0 | %
Add back: |  |  |  |  |  |  |
Depreciation and amortization of intangible assets | 3,461 |  |  | 3,654 |  |  | 10,726 |  |  | 11,267 |
Adjusted Segment EBITDA | $ | 68,094 |  |  | $ | 53,519 |  |  | $ | 165,450 |  |  | $ | 165,683 |
Gross profit (1) | $ | 116,060 |  |  | $ | 93,188 |  |  | $ | 313,626 |  |  | $ | 284,003 |
Percentage change in gross profit from prior year | 24.5 | % |  | 4.9 | % |  | 10.4 | % |  | 21.8 | %
Gross profit margin (2) | 33.4 | % |  | 33.0 | % |  | 32.0 | % |  | 33.7 | %
Adjusted Segment EBITDA as a percentage of revenues | 19.6 | % |  | 19.0 | % |  | 16.9 | % |  | 19.7 | %
Number of revenue-generating professionals (at period end) | 2,251 |  |  | 2,050 |  |  | 2,251 |  |  | 2,050 |
Percentage change in number of revenue-generating professionals from prior year | 9.8 | % |  | 13.0 | % |  | 9.8 | % |  | 13.0 | %
Utilization rate of billable professionals | 60 | % |  | 61 | % |  | 59 | % |  | 62 | %
Average billable rate per hour | $ | 514 |  |  | $ | 445 |  |  | $ | 492 |  |  | $ | 448 |

(1)Revenues less direct cost of revenues
(2)Gross profit as a percentage of revenues
(3)Effective July 1, 2023, Corporate Finance and FLC segment information for the prior periods has been recast in this Quarterly Report on Form 10-Q to include the reclassification of the portion of the Company’s health solutions practice in the FLC segment to our business transformation & strategy practice within our Corporate Finance segment.
Three Months Ended September 30, 2023 Compared with Three Months Ended September 30, 2022
Revenues increased $65.5 million, or 23.2%, to $347.6 million for the three months ended September 30, 2023, which included a 1.1% estimated positive impact from FX. Excluding the estimated impact from FX, revenues increased $62.5 million, or 22.2%, primarily due to higher realized bill rates and demand for our restructuring and business transformation & strategy services, as well as an increase in success fees.
Gross profit increased $22.9 million, or 24.5%, to $116.1 million for the three months ended September 30, 2023. Gross profit margin increased 0.4 percentage points for the three months ended September 30, 2023. The increase in gross profit margin was primarily due to higher success fees.
SG&A expenses increased $9.0 million, or 21.6%, to $50.4 million for the three months ended September 30, 2023, which included a 1.1% estimated negative impact from FX. SG&A expenses of 14.5% of revenues for the three months ended September 30, 2023 compared with 14.7% of revenues for the three months ended September 30, 2022. The increase in SG&A expenses was primarily due to higher infrastructure support, bad debt, and travel and entertainment expenses.
Nine Months Ended September 30, 2023 Compared with Nine Months Ended September 30, 2022
Revenues increased $139.3 million, or 16.6%, to $981.1 million for the nine months ended September 30, 2023, primarily due to higher realized bill rates and demand for our restructuring and business transformation & strategy services and an increase in success fees, which was partially offset by lower demand for our transaction services.
28

Gross profit increased $29.6 million, or 10.4%, to $313.6 million for the nine months ended September 30, 2023. Gross profit margin decreased 1.8 percentage points for the nine months ended September 30, 2023. The decrease in gross profit margin was primarily due to a 3 percentage point decline in utilization and higher contractor costs, which was partially offset by higher success fees.
SG&A expenses increased $31.3 million, or 25.3%, to $154.8 million for the nine months ended September 30, 2023. SG&A expenses of 15.8% of revenues for the nine months ended September 30, 2023 compared with 14.7% of revenues for the nine months ended September 30, 2022. The increase in SG&A expenses was primarily due to higher infrastructure support, business development, bad debt, compensation, travel and entertainment, and other general and administrative expenses.
FORENSIC AND LITIGATION CONSULTING

| Three Months Ended September 30, |  | Nine Months Ended September 30,
| 2023 |  | 2022 (3) |  | 2023 |  | 2022 (3)
| (dollars in thousands, except rate per hour) |  | (dollars in thousands, except rate per hour)
Revenues | $ | 166,137 |  |  | $ | 143,289 |  |  | $ | 488,636 |  |  | $ | 432,054 |
Percentage change in revenues from prior year | 15.9 | % |  | 4.8 | % |  | 13.1 | % |  | 3.3 | %
Operating expenses |  |  |  |  |  |  |
Direct cost of revenues | 110,920 |  |  | 98,302 |  |  | 326,992 |  |  | 304,839 |
Selling, general and administrative expenses | 35,285 |  |  | 30,092 |  |  | 97,132 |  |  | 84,834 |
Amortization of intangible assets | 224 |  |  | 242 |  |  | 631 |  |  | 735 |
| 146,429 |  |  | 128,636 |  |  | 424,755 |  |  | 390,408 |
Segment operating income | 19,708 |  |  | 14,653 |  |  | 63,881 |  |  | 41,646 |
Percentage change in segment operating income from prior year | 34.5 | % |  | -10.8 | % |  | 53.4 | % |  | -29.1 | %
Add back: |  |  |  |  |  |  |
Depreciation and amortization of intangible assets | 1,772 |  |  | 1,522 |  |  | 4,980 |  |  | 4,818 |
Adjusted Segment EBITDA | $ | 21,480 |  |  | $ | 16,175 |  |  | $ | 68,861 |  |  | $ | 46,464 |
Gross profit (1) | $ | 55,217 |  |  | $ | 44,987 |  |  | $ | 161,644 |  |  | $ | 127,215 |
Percentage change in gross profit from prior year | 22.7 | % |  | 9.2 | % |  | 27.1 | % |  | -2.2 | %
Gross profit margin (2) | 33.2 | % |  | 31.4 | % |  | 33.1 | % |  | 29.4 | %
Adjusted Segment EBITDA as a percentage of revenues | 12.9 | % |  | 11.3 | % |  | 14.1 | % |  | 10.8 | %
Number of revenue-generating professionals (at period end) | 1,503 |  |  | 1,464 |  |  | 1,503 |  |  | 1,464 |
Percentage change in number of revenue-generating professionals from prior year | 2.7 | % |  | 7.2 | % |  | 2.7 | % |  | 7.2 | %
Utilization rate of billable professionals | 57 | % |  | 53 | % |  | 58 | % |  | 55 | %
Average billable rate per hour | $ | 388 |  |  | $ | 360 |  |  | $ | 384 |  |  | $ | 355 |

(1)Revenues less direct cost of revenues
(2)Gross profit as a percentage of revenues
(3)Effective July 1, 2023, Corporate Finance and FLC segment information for the prior periods has been recast in this Quarterly Report on Form 10-Q to include the reclassification of the portion of the Company’s health solutions practice in the FLC segment to our business transformation & strategy practice within our Corporate Finance segment.
Three Months Ended September 30, 2023 Compared with Three Months Ended September 30, 2022
Revenues increased $22.8 million, or 15.9%, to $166.1 million for the three months ended September 30, 2023, primarily due to higher demand for our investigations, data & analytics, and construction solutions services.
Gross profit increased $10.2 million, or 22.7%, to $55.2 million for the three months ended September 30, 2023. Gross profit margin increased 1.8 percentage points for the three months ended September 30, 2023. The increase in gross profit margin was primarily due to a 4 percentage point increase in utilization.
29

SG&A expenses increased $5.2 million, or 17.3%, to $35.3 million for the three months ended September 30, 2023. SG&A expenses of 21.2% of revenues for the three months ended September 30, 2023 compared with 21.0% of revenues for the three months ended September 30, 2022. The increase in SG&A expenses was primarily driven by higher infrastructure support, compensation and bad debt expenses.
Nine Months Ended September 30, 2023 Compared with Nine Months Ended September 30, 2022
Revenues increased $56.6 million, or 13.1%, to $488.6 million for the nine months ended September 30, 2023, primarily due to higher demand and realized bill rates for our investigations and data & analytics services.
Gross profit increased $34.4 million, or 27.1%, to $161.6 million for the nine months ended September 30, 2023. Gross profit margin increased 3.6 percentage points for the nine months ended September 30, 2023. The increase in gross profit margin was primarily due to a 3 percentage point increase in utilization.
SG&A expenses increased $12.3 million, or 14.5%, to $97.1 million for the nine months ended September 30, 2023. SG&A expenses of 19.9% of revenues for the nine months ended September 30, 2023 compared with 19.6% of revenues for the nine months ended September 30, 2022. The increase in SG&A expenses was primarily driven by higher infrastructure support, compensation, and travel and entertainment expenses.
ECONOMIC CONSULTING

| Three Months Ended September 30, |  | Nine Months Ended September 30,
| 2023 |  | 2022 |  | 2023 |  | 2022
| (dollars in thousands, except rate per hour) |  | (dollars in thousands, except rate per hour)
Revenues | $ | 193,866 |  |  | $ | 193,183 |  |  | $ | 565,283 |  |  | $ | 523,201 |
Percentage change in revenues from prior year | 0.4 | % |  | 12.0 | % |  | 8.0 | % |  | -0.4 | %
Operating expenses |  |  |  |  |  |  |
Direct cost of revenues | 138,423 |  |  | 140,781 |  |  | 412,547 |  |  | 387,257 |
Selling, general and administrative expenses | 29,150 |  |  | 20,728 |  |  | 79,719 |  |  | 63,888 |
| 167,573 |  |  | 161,509 |  |  | 492,266 |  |  | 451,145 |
Segment operating income | 26,293 |  |  | 31,674 |  |  | 73,017 |  |  | 72,056 |
Percentage change in segment operating income from prior year | -17.0 | % |  | 11.3 | % |  | 1.3 | % |  | -13.1 | %
Add back: |  |  |  |  |  |  |
Depreciation and amortization | 1,463 |  |  | 1,239 |  |  | 4,455 |  |  | 3,698 |
Adjusted Segment EBITDA | $ | 27,756 |  |  | $ | 32,913 |  |  | $ | 77,472 |  |  | $ | 75,754 |
Gross profit (1) | $ | 55,443 |  |  | $ | 52,402 |  |  | $ | 152,736 |  |  | $ | 135,944 |
Percentage change in gross profit from prior year | 5.8 | % |  | 5.9 | % |  | 12.4 | % |  | -3.8 | %
Gross profit margin (2) | 28.6 | % |  | 27.1 | % |  | 27.0 | % |  | 26.0 | %
Adjusted Segment EBITDA as a percentage of revenues | 14.3 | % |  | 17.0 | % |  | 13.7 | % |  | 14.5 | %
Number of revenue-generating professionals (at period end) | 1,085 |  |  | 998 |  |  | 1,085 |  |  | 998 |
Percentage change in number of revenue-generating professionals from prior year | 8.7 | % |  | 7.9 | % |  | 8.7 | % |  | 7.9 | %
Utilization rate of billable professionals | 65 | % |  | 67 | % |  | 67 | % |  | 70 | %
Average billable rate per hour | $ | 559 |  |  | $ | 579 |  |  | $ | 533 |  |  | $ | 506 |

(1)Revenues less direct cost of revenues
(2)Gross profit as a percentage of revenues
30

Three Months Ended September 30, 2023 Compared with Three Months Ended September 30, 2022
Revenues increased $0.7 million, or 0.4%, to $193.9 million for the three months ended September 30, 2023, which included a 2.2% estimated positive impact from FX. Excluding the estimated impact from FX, revenues decreased $3.5 million, or 1.8%. The decrease in revenues was primarily due to lower realized bill rates for our non-M&A-related antitrust services compared to the three months ended September 30, 2022, which included $21.4 million of revenues recognized that were previously deferred on one large client, which was partially offset by increased demand for our non-M&A-related antitrust and international arbitration services, and higher realized bill rates for our M&A-related antitrust services.
Gross profit increased $3.0 million, or 5.8%, to $55.4 million for the three months ended September 30, 2023. Gross profit margin increased 1.5 percentage points for the three months ended September 30, 2023. The increase in gross profit margin was primarily due to lower variable compensation expenses as a percentage of revenues, which was partially offset by a 2 percentage point decline in utilization.
SG&A expenses increased $8.4 million, or 40.6%, to $29.2 million for the three months ended September 30, 2023, which included a 3.0% estimated negative impact from FX. SG&A expenses of 15.0% of revenues for the three months ended September 30, 2023 compared with 10.7% of revenues for the three months ended September 30, 2022. The increase in SG&A expenses was primarily driven by higher bad debt, infrastructure support, compensation, and other general and administrative expenses.
Nine Months Ended September 30, 2023 Compared with Nine Months Ended September 30, 2022
Revenues increased $42.1 million, or 8.0%, to $565.3 million for the nine months ended September 30, 2023, primarily due to increased demand for our international arbitration, M&A-related antitrust and non-M&A-related antitrust services.
Gross profit increased $16.8 million, or 12.4%, to $152.7 million for the nine months ended September 30, 2023. Gross profit margin increased 1.0 percentage point for the nine months ended September 30, 2023. The increase in gross profit margin was primarily due to lower variable compensation expenses as a percentage of revenues, which was partially offset by a 3 percentage point decline in utilization.
SG&A expenses increased $15.8 million, or 24.8%, to $79.7 million for the nine months ended September 30, 2023. SG&A expenses of 14.1% of revenues for the nine months ended September 30, 2023 compared with 12.2% of revenues for the nine months ended September 30, 2022. The increase in SG&A expenses was primarily driven by higher infrastructure support, bad debt, compensation, outside services, and other general and administrative expenses.
31

TECHNOLOGY

| Three Months Ended September 30, |  | Nine Months Ended September 30,
| 2023 |  | 2022 |  | 2023 |  | 2022
| (dollars in thousands) |  | (dollars in thousands)
Revenues | $ | 98,860 |  |  | $ | 84,915 |  |  | $ | 286,922 |  |  | $ | 243,181 |
Percentage change in revenues from prior year | 16.4 | % |  | 31.3 | % |  | 18.0 | % |  | 9.2 | %
Operating expenses |  |  |  |  |  |  |
Direct cost of revenues | 61,538 |  |  | 54,027 |  |  | 176,066 |  |  | 158,498 |
Selling, general and administrative expenses | 25,841 |  |  | 21,055 |  |  | 71,053 |  |  | 59,678 |
| 87,379 |  |  | 75,082 |  |  | 247,119 |  |  | 218,176 |
Segment operating income | 11,481 |  |  | 9,833 |  |  | 39,803 |  |  | 25,005 |
Percentage change in segment operating income from prior year | 16.8 | % |  | 122.7 | % |  | 59.2 | % |  | -34.7 | %
Add back: |  |  |  |  |  |  |
Depreciation and amortization | 3,392 |  |  | 3,380 |  |  | 10,523 |  |  | 9,935 |
Adjusted Segment EBITDA | $ | 14,873 |  |  | $ | 13,213 |  |  | $ | 50,326 |  |  | $ | 34,940 |
Gross profit (1) | $ | 37,322 |  |  | $ | 30,888 |  |  | $ | 110,856 |  |  | $ | 84,683 |
Percentage change in gross profit from prior year | 20.8 | % |  | 40.3 | % |  | 30.9 | % |  | -4.7 | %
Gross profit margin (2) | 37.8 | % |  | 36.4 | % |  | 38.6 | % |  | 34.8 | %
Adjusted Segment EBITDA as a percentage of revenues | 15.0 | % |  | 15.6 | % |  | 17.5 | % |  | 14.4 | %
Number of revenue-generating professionals (at period end) (3) | 629 |  |  | 548 |  |  | 629 |  |  | 548 |
Percentage change in number of revenue-generating professionals from prior year | 14.8 | % |  | 23.7 | % |  | 14.8 | % |  | 23.7 | %

(1)Revenues less direct cost of revenues
(2)Gross profit as a percentage of revenues
(3)Includes personnel involved in direct client assistance and revenue-generating consultants and excludes professionals employed on an as-needed basis.
Three Months Ended September 30, 2023 Compared with Three Months Ended September 30, 2022
Revenues increased $13.9 million, or 16.4%, to $98.9 million for the three months ended September 30, 2023, which included a 1.8% estimated positive impact from FX. Excluding the estimated impact from FX, revenues increased $12.5 million, or 14.7%, primarily due to higher demand for investigations and litigation services, which was partially offset by lower demand for M&A-related “second request” services.
Gross profit increased $6.4 million, or 20.8%, to $37.3 million for the three months ended September 30, 2023. Gross profit margin increased 1.4 percentage points for the three months ended September 30, 2023. The increase in gross profit margin was primarily due to higher profitability in our consulting services and an increased mix of our higher margin hosting services, which was partially offset by lower profitability in our managed review services.
SG&A expenses increased $4.8 million, or 22.7%, to $25.8 million for the three months ended September 30, 2023, which included a 1.6% estimated negative impact from FX. SG&A expenses of 26.1% of revenues for the three months ended September 30, 2023 compared with 24.8% of revenues for the three months ended September 30, 2022. The increase in SG&A expenses was primarily due to higher compensation, infrastructure support and bad debt expenses.
Nine Months Ended September 30, 2023 Compared with Nine Months Ended September 30, 2022
Revenues increased $43.7 million, or 18.0%, to $286.9 million for the nine months ended September 30, 2023. The increase in revenues was primarily due to increased demand for investigations and litigation services, which was partially offset by lower demand for M&A-related “second request” services.
Gross profit increased $26.2 million, or 30.9%, to $110.9 million for the nine months ended September 30, 2023. Gross profit margin increased 3.8 percentage points for the nine months ended September 30, 2023. The increase in gross profit margin was primarily due to an increased mix of our higher margin hosting services and increased profitability in our consulting services.
32

SG&A expenses increased $11.4 million, or 19.1%, to $71.1 million for the nine months ended September 30, 2023. SG&A expenses of 24.8% of revenues for the nine months ended September 30, 2023 compared with 24.5% of revenues for the nine months ended September 30, 2022. The increase in SG&A expenses was primarily due to higher infrastructure support, compensation, bad debt, and travel and entertainment expenses.
STRATEGIC COMMUNICATIONS

| Three Months Ended September 30, |  | Nine Months Ended September 30,
| 2023 |  | 2022 |  | 2023 |  | 2022
| (dollars in thousands) |  | (dollars in thousands)
Revenues | $ | 86,838 |  |  | $ | 72,449 |  |  | $ | 242,593 |  |  | $ | 214,237 |
Percentage change in revenues from prior year | 19.9 | % |  | 4.3 | % |  | 13.2 | % |  | 8.3 | %
Operating expenses |  |  |  |  |  |  |
Direct cost of revenues | 56,422 |  |  | 44,681 |  |  | 157,304 |  |  | 131,421 |
Selling, general and administrative expenses | 17,844 |  |  | 15,450 |  |  | 52,586 |  |  | 44,645 |
Amortization of intangible assets | 69 |  |  | 163 |  |  | 239 |  |  | 548 |
| 74,335 |  |  | 60,294 |  |  | 210,129 |  |  | 176,614 |
Segment operating income | 12,503 |  |  | 12,155 |  |  | 32,464 |  |  | 37,623 |
Percentage change in segment operating income from prior year | 2.9 | % |  | -14.5 | % |  | -13.7 | % |  | 5.9 | %
Add back: |  |  |  |  |  |  |
Depreciation and amortization of intangible assets | 951 |  |  | 792 |  |  | 2,809 |  |  | 2,510 |
Adjusted Segment EBITDA | $ | 13,454 |  |  | $ | 12,947 |  |  | $ | 35,273 |  |  | $ | 40,133 |
Gross profit (1) | $ | 30,416 |  |  | $ | 27,768 |  |  | $ | 85,289 |  |  | $ | 82,816 |
Percentage change in gross profit from prior year | 9.5 | % |  | -2.3 | % |  | 3.0 | % |  | 10.2 | %
Gross profit margin (2) | 35.0 | % |  | 38.3 | % |  | 35.2 | % |  | 38.7 | %
Adjusted Segment EBITDA as a percentage of revenues | 15.5 | % |  | 17.9 | % |  | 14.5 | % |  | 18.7 | %
Number of revenue-generating professionals (at period end) | 1,010 |  |  | 951 |  |  | 1,010 |  |  | 951 |
Percentage change in number of revenue-generating professionals from prior year | 6.2 | % |  | 16.4 | % |  | 6.2 | % |  | 16.4 | %

(1)Revenues less direct cost of revenues
(2)Gross profit as a percentage of revenues
Three Months Ended September 30, 2023 Compared with Three Months Ended September 30, 2022
Revenues increased $14.4 million, or 19.9%, to $86.8 million for the three months ended September 30, 2023, which included a 3.2% estimated positive impact from FX. Excluding the estimated impact from FX, revenues increased $12.1 million, or 16.7%, primarily driven by higher demand for our corporate reputation and public affairs services.
Gross profit increased $2.6 million, or 9.5%, to $30.4 million for the three months ended September 30, 2023. Gross profit margin decreased 3.3 percentage points for the three months ended September 30, 2023. The decrease in gross profit margin was primarily driven by higher compensation expenses as a percentage of revenues, which included the impact of a 6.2% increase in billable headcount.
SG&A expenses increased $2.4 million, or 15.5%, to $17.8 million for the three months ended September 30, 2023, which included a 2.9% estimated negative impact from FX. SG&A expenses of 20.5% of revenues for the three months ended September 30, 2023 compared with 21.3% of revenues for the three months ended September 30, 2022. The increase in SG&A expenses was primarily driven by higher infrastructure support and compensation expenses.
Nine Months Ended September 30, 2023 Compared with Nine Months Ended September 30, 2022
Revenues increased $28.4 million, or 13.2%, to $242.6 million for the nine months ended September 30, 2023, primarily driven by higher demand for our public affairs and corporate reputation services.
33

Gross profit increased $2.5 million, or 3.0%, to $85.3 million for the nine months ended September 30, 2023. Gross profit margin decreased 3.5 percentage points for the nine months ended September 30, 2023. The decrease in gross profit margin was primarily driven by higher compensation expenses as a percentage of revenues, which included the impact of a 6.2% increase in billable headcount.
SG&A expenses increased $7.9 million, or 17.8%, to $52.6 million for the nine months ended September 30, 2023. SG&A expenses of 21.7% of revenues for the nine months ended September 30, 2023 compared with 20.8% of revenues for the nine months ended September 30, 2022. The increase in SG&A expenses was primarily driven by higher infrastructure support, travel and entertainment and compensation expenses.
CRITICAL ACCOUNTING ESTIMATES
Our discussion and analysis of our financial condition and results of operations are based on our condensed consolidated financial statements, which we have prepared in accordance with GAAP. The preparation of these financial statements requires us to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses, and related disclosure of contingent assets and liabilities. Note 1 to the Consolidated Financial Statements included in Part II, Item 8, of our Annual Report on Form 10-K for the year ended December 31, 2022 describes the significant accounting policies and methods used in preparation of the Condensed Consolidated Financial Statements in this Quarterly Report on Form 10-Q. We evaluate our estimates, including those related to revenues, goodwill and intangible assets, income taxes and contingencies, on an ongoing basis. Our estimates are based on current facts and circumstances, historical experience and various other assumptions that we believe are reasonable, which form the basis for making judgments about the values of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions or conditions. The accounting estimates that reflect our more significant judgments, and which we believe are the most critical to aid in fully understanding and evaluating our reported financial results, include the following:
•Revenue Recognition
•Goodwill and Intangible Assets
There were no material changes to our critical accounting estimates from the information provided in “Critical Accounting Estimates” in the Management’s Discussion and Analysis of Financial Condition and Results of Operations, in Part II, Item 7, of our Annual Report on Form 10-K for the year ended December 31, 2022, or from the information provided in Part II, Item 8, of our Annual Report on Form 10-K for the year ended December 31, 2022.
LIQUIDITY AND CAPITAL RESOURCES
Liquidity
Our annual cash flows from operations generally exceed our cash needs for capital expenditures and debt service requirements. We typically finance our day-to-day operations, capital expenditures, acquisitions and share repurchases through cash flows from operations. During the first quarter of each fiscal year, our cash needs generally exceed our cash flows from operations due to the payment of annual incentive compensation. We believe that our cash flows from operations, supplemented by borrowings under our Credit Facility, as necessary, will provide adequate cash to fund our cash needs for at least the next 12 months.
Our operating assets and liabilities consist primarily of billed and unbilled accounts receivable, notes receivable from employees, accounts payable, accrued expenses and accrued compensation expenses. The timing of billings and collections of receivables, as well as compensation and vendor payments, affects the changes in these balances.
Results of operations for our non-U.S. subsidiaries are translated from the designated functional currency to our reporting currency of USD. Revenues and expenses are translated at average exchange rates for each month, while assets and liabilities are translated at balance sheet date exchange rates. Resulting net translation adjustments are recorded as a component of stockholders’ equity in “Accumulated other comprehensive loss.”
34

Uncertainties and Trends Affecting Liquidity
Our conclusion that we will be able to fund our cash requirements for at least the next 12 months by using existing capital resources and cash generated from operations does not take into account events beyond our control that could result in a material adverse impact on our business, the impact of any future acquisitions or unexpected significant changes in the number of employees or other unanticipated uses of cash. The anticipated cash needs of our business could change significantly if we pursue and complete additional business acquisitions, if our business plans change, if events such as economic and workforce disruptions arise, including any future impact of pandemics such as COVID-19 or other future public health crises, or economic or business conditions change from those currently prevailing or from those now anticipated, or if unexpected circumstances or other events beyond our control arise that may have a material effect on the cash flow or profitability of our business, including material negative changes in the health and welfare of our employees or those of our clients, and the operating performance or financial results of our business. Any of these events or circumstances, including any new business opportunities, could involve significant additional funding and could require us to borrow under our Credit Facility or raise additional debt or equity funding to meet those needs. Our ability to borrow or raise additional capital, if necessary, is subject to a variety of factors that we cannot predict with certainty, including:
•our future profitability;
•the quality of our accounts receivable;
•our relative levels of debt and equity;
•the volatility and overall condition of the capital markets; and
•the market prices of our securities.
Any new debt funding, if available, may be on terms less favorable to us than our Credit Facility. See “Forward-Looking Statements” in Part I, Item 2, of this Quarterly Report on Form 10-Q, and the information contained under the heading “Risk Factors” in Part I, Item 1A, of our Annual Report on Form 10-K for the year ended December 31, 2022.
Cash Flows

| Nine Months Ended September 30,
| 2023 |  | 2022
Cash Flows | (dollars in thousands)
Net cash used in operating activities | $ | (158,525) |  |  | $ | (40,439) |
Net cash used in investing activities | $ | (67,580) |  |  | $ | (45,677) |
Net cash used in financing activities | $ | (67,080) |  |  | $ | (36,949) |
Effect of exchange rate changes on cash and cash equivalents | $ | 2,645 |  |  | $ | (44,373) |
DSO (1) | 114 |  |  | 106 |

(1)DSO is a performance measure used to assess how quickly revenues are collected by the Company. We calculate DSO at the end of each reporting period by dividing net accounts receivable reduced by billings in excess of services provided, by revenues for the quarter, adjusted for changes in foreign exchange rates. We multiply the result by the number of days in the quarter.
Nine Months Ended September 30, 2023 Compared with Nine Months Ended September 30, 2022
Net c ash used in operating activities of $158.5 million for the nine months ended September 30, 2023 compared to $40.4 million for the nine months ended September 30, 2022. The increase of $118.1 million, or 292.0%, in net cash used in operating activities was primarily due to cash collections not keeping pace with the increase in revenues and not sufficiently offsetting the increase in salaries and other employee cash compensation, largely related to headcount growth, and higher operating expenses and income tax payments. DSO was 114 and 106 days as of September 30, 2023 and 2022, respectively. The increase in DSO was primarily due to cash collections that have not kept pace with higher revenues.
Net cash used in investing activities of $67.6 million for the nine months ended September 30, 2023 compared to $45.7 million for the nine months ended September 30, 2022. The increase of $21.9 million, or 48.0%, in net cash used in investing activities was primarily due to a $24.4 million payment for a short-term investment during the nine months ended September 30, 2023, as there were no payments for short-term investments during the nine months ended September 30, 2022, and a $4.3
35

million increase in capital expenditures. These increases were partially offset by a $6.7 million decrease in payments for the acquisition of businesses, as there were no acquisitions of businesses during the nine months ended September 30, 2023.
Net cash used in financing activities of $67.1 million for the nine months ended September 30, 2023 compared to $36.9 million for the nine months ended September 30, 2022. The increase of $30.1 million, or 81.5%, in net cash used in financing activities was primarily due to the repayment of the $315.8 million principal amount of our 2023 Convertible Notes at maturity, which was partially offset by an increase in net borrowings of $285.0 million under our Credit Facility.
The effect of exchange rate changes on cash and cash equivalents had a favorable impact of $2.6 million for the nine months ended September 30, 2023 compared to an unfavorable impact of $44.4 million for the nine months ended September 30, 2022.
Principal Sources of Capital Resources
As of September 30, 2023, our capital resources included $201.1 million of cash and cash equivalents, a $24.4 million short-term investment and available borrowing capacity of $614.9 million under the $900.0 million revolving line of credit under our Credit Facility. As of September 30, 2023, we had $285.0 million of outstanding borrowings under our Credit Facility and $0.1 million of outstanding letters of credit, which reduced the availability of borrowings under the Credit Facility. We use letters of credit primarily in lieu of security deposits for our leased office facilities. The $900.0 million revolving line of credit under our Credit Facility includes a $125.0 million sublimit for borrowings in currencies other than USD, including the euro, British pound, Australian dollar, Canadian dollar, Swiss franc and Japanese yen.
The availability of borrowings, as well as issuances and extensions of letters of credit under our Credit Facility, are subject to specified conditions. Subject to certain conditions, at any time prior to maturity, we will be able to invite existing and new lenders to increase the size of the facility up to a maximum of $1.2 billion. See Note 8, “Debt” in Part I, Item 1, of this Quarterly Report on Form 10-Q for a further discussion of borrowing rates and guarantees under the Credit Facility.
The second amended and restated credit agreement entered into on November 21, 2022 (the “Credit Agreement”) governing the Credit Facility and our other indebtedness outstanding from time to time contains covenants that, among other things, may limit our ability to: incur additional indebtedness; create liens; pay dividends on our capital stock, make distributions or repurchases of our capital stock or make specified other restricted payments; consolidate, merge or sell all or substantially all of our assets; guarantee obligations of other entities or our foreign subsidiaries; enter into hedging agreements; enter into transactions with affiliates or related persons; or engage in any business other than consulting-related businesses. In addition, the Credit Agreement includes a financial covenant that requires us not to exceed a maximum consolidated total net leverage ratio (the ratio of funded debt (less unrestricted cash up to $300.0 million) to Consolidated EBITDA, as defined in the Credit Agreement). As of September 30, 2023, we were in compliance with the covenants contained in the Credit Agreement. See Note 8, “Debt” in Part I, Item 1, of this Quarterly Report on Form 10-Q for a further discussion of the Credit Agreement.
Principal Uses of Capital Resources
Future Capital Requirements
We anticipate that our future capital requirements will principally consist of funds required for:
•operating and general corporate expenses relating to the operation of our businesses;
•capital expenditures, primarily for information technology equipment and information or financial systems, office furniture and leasehold improvements;
•debt service requirements, including interest payments on our long-term debt;
•compensation to designated executive management and senior managing directors under our various long-term incentive compensation programs;
•discretionary funding of the Repurchase Program;
•contingent obligations related to our acquisitions;
•potential acquisitions of businesses; and
•other known future contractual obligations.
36

Capital Expenditures
During the nine months ended September 30, 2023, we spent $43.3 million in capital expenditures to support our organization, including direct support for specific client engagements. For the remainder of 2023, we currently expect additional capital expenditures to support our organization in an aggregate amount of between $6 million and $8 million. Our estimate takes into consideration the needs of our existing businesses but does not include the impact of any purchases that we may be required to make as a result of future acquisitions or specific client engagements that are not completed or not currently contemplated. Our capital expenditure requirements may change if our staffing levels or technology needs change significantly from what we currently anticipate, if we are required to purchase additional equipment specifically to support new client engagements, or if we pursue and complete additional acquisitions.
Share Repurchase Program
During the nine months ended September 30, 2023, we made $21.0 million in payments for common stock repurchases under the Repurchase Program. We had $460.7 million remaining under the Repurchase Program to repurchase additional shares as of September 30, 2023.
Future Contractual Obligations
Our future contractual obligations as of September 30, 2023 include long-term obligations of $285.0 million related to outstanding borrowings under our Credit Facility. For more information on our Credit Facility, refer to Note 8, “Debt” in Part I, Item 1. Future contractual obligations related to our debt assume that payments will be made based on the current payment schedule and that interest pa yments will be at their stated rates and exclude any additional revolving line of credit borrowings or repayments subsequent to September 30, 2023 and prior to the November 21, 2027 maturity date of our Credit Facility. Under our operating leases as described in Note 9, “Leases” in Part I, Item 1, we have current obligations of $33.1 million and non-current obligations of $217.8 million.
These amounts reflect future unconditional payments and are based on the terms of the relevant agreements, appropriate classification of items under GAAP currently in effect and certain assumptions such as interest rates. Future events could cause actual payments to differ from these amounts.
Forward-Looking Statements
This Quarterly Report on Form 10-Q includes “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended (the “Securities Act”), and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), that involve uncertainties and risks. Forward-looking statements include statements concerning our plans, initiatives, projections, prospects, policies and practices, objectives, goals, commitments, strategies, future events, future revenues, future results and performance, future capital allocations and expenditures, expectations, plans or intentions relating to acquisitions, share repurchases and other matters, business trends, new, or changes to, laws and regulations, including U.S. and foreign tax laws, environmental, social and governance (“ESG”)-related issues, climate change-related matters, scientific or technological developments and other information that is not historical. Forward-looking statements often contain words such as “estimates,” “expects,” “anticipates,” “projects,” “plans,” “intends,” “believes,” “commits,” “aspires,” “forecasts,” “future,” “goal,” “seeks” and variations of such words or similar expressions. All forward-looking statements, including, without limitation, management’s financial guidance and examination of operating trends, are based upon our historical performance and our current plans, estimates, intentions and expectations at the time we make them, and various assumptions. Our actual financial results, performance or achievements and outcomes could differ materially from those expressed in, or implied by, any forward-looking statements. Any references to standards of measurement and performance made regarding our climate change-, ESG- or other sustainability-related plans, goals, commitments, intentions, aspirations, forecasts or projections, or expectations are developing and based on assumptions. There can be no assurance that management’s plans, performance, expectations, intentions, aspirations, beliefs, goals, estimates, forecasts and projections, including any that are ESG- or other sustainability-related, will result or be achieved, and the inclusion of any forward-looking information should not be regarded as a representation by us or any other person that the future plans, estimates, forecasts, intentions, aspirations, beliefs or expectations contemplated by us will be achieved. Given these risks, uncertainties and other factors, you should not place undue reliance on any forward-looking statements.
There are a number of risks and uncertainties that could cause our actual results to differ materially from the forward-looking statements contained in, or implied by, this Quarterly Report on Form 10-Q. Important factors that could cause our actual results to differ materially from the forward-looking statements we make in this Quarterly Report on Form 10-Q include those set forth under the heading “Risk Factors” in Part I, Item 1A, of our Annual Report on Form 10-K for the year ended December 31, 2022, as well as in other information that we file with the SEC from time to time. Important factors that could
37

cause our actual results to differ materially from the forward-looking statements we make in this Quarterly Report on Form 10-Q include, but are not limited to, the following:
•changes in demand for our services;
•our ability to recruit and retain qualified professionals and senior management, including segment, industry and regional leaders;
•conflicts resulting in our inability to represent certain clients;
•our former employees joining or forming competing businesses;
•our ability to manage our headcount needs and our professionals’ utilization and billing rates and maintain or increase the pricing of our services and products;
•our ability to identify suitable acquisition candidates, negotiate favorable terms, take advantage of opportunistic acquisition situations and integrate the operations of acquisitions, as well as the costs of integration;
•our ability to adapt to and manage the risks associated with operating in non-U.S. markets;
•our ability to replace key personnel, including former executives, officers, senior managers and practice and regional leaders who have highly specialized skills and experience;
•our ability to protect the confidentiality of internal and client data and proprietary and confidential information, including from cyberattacks, systems failures or other similar events, or the use or misuse of social media;
•legislation or judicial rulings, including legislation or rulings regarding data privacy and the discovery process;
•periodic fluctuations in revenues, operating income and cash flows;
•damage to our reputation as a result of claims involving the quality of our services, failures of our internal information technology systems controls or adverse publicity relating to certain clients or engagements;
•fee discounting or renegotiation, lower pricing, less advantageous contract terms and unexpected termination of client engagements;
•competition for clients and key personnel;
•general economic factors, industry trends, restructuring and bankruptcy rates, legal or regulatory requirements, capital market conditions, merger and acquisition activity, major litigation activity and other events outside of our control;
•our ability to manage growth;
•risk of non-payment of receivables;
•the amount and terms of our outstanding indebtedness;
•risks relating to the obsolescence, replacement, protection, implementation or operation of our information technology systems, including our enterprise resource planning (“ERP”) and other financial systems, and software, proprietary software products, intellectual property rights and trade secrets, which could adversely affect our ability to retain or win clients, conduct business, preserve or enhance our reputation, maintain business continuity or report financial results;
•foreign currency disruptions and currency fluctuations between the U.S. dollar and foreign currencies;
•U.S. and foreign tax law changes, including the enactment of tax legislation, proposed from time-to-time, into law, which could increase our effective tax rate and cash tax expenditures;
•physical risks related to climate change, including rising temperatures, severe storms, energy disruptions and rising sea levels, among others, which could adversely impact our ability to conduct business or maintain business continuity, including by affecting our access to our leased office space in affected geographies and the integrity of our information technology systems;
38

•our climate change and ESG-related initiatives and goals, including our policies and practices relating to the environment and climate change, sustainability, and diversity and inclusion, if they do not meet or keep pace with evolving governmental, investor or other stakeholder expectations and standards or rules and regulations;
•fluctuations in the mix of our services and the geographic locations in which our clients are located or our services are rendered; and
•the future impact of any pandemics such as COVID-19 or other future public health crises could have adverse and disparate impacts on the Company, our employees, clients and geographic regions in which we conduct business.
There may be other factors that may cause our actual results to differ materially from our forward-looking statements. All forward-looking statements attributable to us or persons acting on our behalf apply only as of the date of this Quarterly Report on Form 10-Q and are expressly qualified in their entirety by the cautionary statements included herein. We undertake no obligation to publicly update or revise any forward-looking statements to reflect subsequent events or circumstances and do not intend to do so.

Item 3. | Quantitative and Qualitative Disclosures About Market Risk

For information regarding our exposure to certain market risks, see “Quantitative and Qualitative Disclosures About Market Risk” in Part II, Item 7A, of our Annual Report on Form 10-K for the year ended December 31, 2022. There have been no mate rial changes in our market risk exposure during the period covered by this Quarterly Report on Form 10-Q.

Item 4. | Controls and Procedures

Evaluation of Disclosure Controls and Procedures. An evaluation of the effectiveness of the design and operation of our “disclosure controls and procedures” (as defined in Rule 13a-15(e) under the Exchange Act), as of the end of the period covered by this Quarterly Report on Form 10-Q, was made under the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer. Based upon this evaluation, our Chief Executive Officer and Chief Financial Officer have concluded that our disclosure controls and procedures (a) were effective to ensure that information required to be disclosed by us in reports filed or submitted under the Exchange Act is timely recorded, processed, summarized and reported and (b) included, without limitation, controls and procedures designed to ensure that information required to be disclosed by us in reports filed or submitted under the Exchange Act is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure.
Changes in Internal Control over Financial Reporting. During the three months ended June 30, 2023, the Company implemented a new ERP system. As part of the implementation, we designed new internal controls and modified and/or enhanced existing internal controls in order to align with the new system and business processes. The Company does not believe this implementation has had or will have in the future a material adverse effect on the Company's internal control over financial reporting. Except as disclosed above, there have not been any additional changes in our internal control over financial reporting during the three months ended September 30, 2023 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.
39

PART II—OTHER INFORMATION

Item 1. | Legal Proceedings

From time to time in the ordinary course of business, we are subject to claims, asserted or unasserted, or named as a party to lawsuits or investigations. Litigation, in general, and intellectual property and securities litigation in particular, can be expensive and disruptive to normal business operations. Moreover, the results of legal proceedings cannot be predicted with any certainty and in the case of more complex legal proceedings such as intellectual property and securities litigation, the results are difficult to predict at all. We are not aware of any asserted or unasserted legal proceedings or claims that we believe would have a material adverse effect on our financial condition or results of our operations.

Item 1A. | Risk Factors

There have been no material changes in any risk factors previously disclosed in Part I, Item 1A, of our Annual Report on Form 10-K for the year ended December 31, 2022 filed with the United States Securities and Exchange Commission (“SEC”). We may disclose changes to risk factors or disclose additional factors from time to time in our future filings with the SEC. Additional risks and uncertainties not presently known to us or that we currently deem immaterial also may impair our business operations.

Item 2. | Unregistered Sales of Equity Securities and Use of Proceeds

Unregistered sales of equity securities.
On August 17, 2023, we issued a total of 1,460,740 shares of our common stock to holders in connection with the conversion of their 2023 Convertible Notes at maturity, which represents the excess of the conversion value over the principal amount of $280.3 million. The shares were issued pursuant to the exemption from registration under Section 3(a)(9) of the Securities Act.
Repurchases of our common stock.
The following table provides information with respect to purchases we made of our common stock during the three months ended September 30, 2023:

| Total Number of Shares Purchased |  | Average Price Paid per Share |  | Total Number of Shares Purchased as Part of Publicly Announced Program (1) |  | Approximate Dollar Value That May Yet Be Purchased Under the Program
| (in thousands, except per share data)
July 1 through July 31, 2023 | 14 |  | (2) | $ | 190.20 |  |  | — |  |  | $ | 460,653 |
August 1 through August 31, 2023 | 1 |  | (3) | $ | 187.34 |  |  | — |  |  | $ | 460,653 |
September 1 through September 30, 2023 | 2 |  | (4) | $ | 178.42 |  |  | — |  |  | $ | 460,653 |
| 17 |  |  |  |  | — |  |  |

(1)On June 2, 2016, our Board of Directors authorized a stock repurchase program of up to $100.0 million (the “Repurchase Program”). On each of May 18, 2017, December 1, 2017, February 21, 2019 and February 20, 2020, our Board of Directors authorized an additional $100.0 million. On each of July 28, 2020 and December 3, 2020, our Board of Directors authorized an additional $200.0 million. On December 1, 2022, our Board of Directors authorized an additional $400.0 million, increasing the Repurchase Program to an aggregate authorization of $1.3 billion. No time limit has been established for the completion of the Repurchase Program, and the Repurchase Program may be suspended, discontinued or replaced by the Board of Directors at any time without prior notice. There were no repurchases of shares of our common stock pursuant to the Repurchase Program during the quarter ended September 30, 2023.
(2)Includes 14,315 shares of common stock withheld to cover payroll tax withholdings related to the lapse of restrictions on restricted stock.
(3)Includes 903 shares of common stock withheld to cover payroll tax withholdings related to the lapse of restrictions on restricted stock.
40

(4)Includes 2,233 shares of common stock withheld to cover payroll tax withholdings related to the lapse of restrictions on restricted stock.

Item 3. | Defaults Upon Senior Securities

None.

Item 4. | Mine Safety Disclosures

Not applicable.

Item 5. | Other Information

(c) Trading plans
During the quarter ended September 30, 2023, no director or Section 16 officer of the Company adopted or terminated any Rule 10b5-1 trading arrangements or non-Rule 10b5-1 trading arrangements (in each case, as defined in Item 408(a) of Regulation S-K).
41

Item 6. | Exhibits

Exhibit Number |  | Description
3.1 |  | Articles of Incorporation of FTI Consulting, Inc., as amended and restated. (Filed with the Securities and Exchange Commission on May 23, 2003 as an exhibit to FTI Consulting, Inc.’s Current Report on Form 8-K dated May 21, 2003 and incorporated herein by reference.)
3.2 |  | Articles of Amendment of FTI Consulting, Inc. (Filed with the Securities and Exchange Commission on June 2, 2011 as an exhibit to FTI Consulting, Inc.’s Current Report on Form 8-K dated June 1, 2011 and incorporated herein by reference.)
3.3 |  | Bylaws of FTI Consulting, Inc., as Amended and Restated Adopted February 20, 2023. (Filed with the Securities and Exchange Commission on February 21, 2023 as an exhibit to FTI Consulting, Inc.’s Current Report on Form 8-K dated February 20, 2023 and incorporated herein by reference.)
31.1† |  | Certification of Principal Executive Officer pursuant to Rule 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as amended (Section 302 of the Sarbanes-Oxley Act of 2002.)
31.2† |  | Certification of Principal Financial Officer pursuant to Rule 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as amended (Section 302 of the Sarbanes-Oxley Act of 2002.)
32.1†** |  | Certification of Principal Executive Officer pursuant to 18 U.S.C. Section 1350 (Section 906 of the Sarbanes-Oxley Act of 2002.)
32.2†** |  | Certification of Principal Financial Officer pursuant to 18 U.S.C. Section 1350 (Section 906 of the Sarbanes-Oxley Act of 2002.)
101 |  | The following financial information from the Quarterly Report on Form 10-Q of FTI Consulting, Inc., included herewith, and formatted in Inline XBRL (eXtensible Business Reporting Language): (i) Condensed Consolidated Balance Sheets as of September 30, 2023 and December 31, 2022; (ii) Condensed Consolidated Statements of Comprehensive Income for the three and nine months ended September 30, 2023 and 2022; (iii) Condensed Consolidated Statements of Stockholders’ Equity for the three and nine months ended September 30, 2023 and 2022; (iv) Condensed Consolidated Statements of Cash Flows for the nine months ended September 30, 2023 and 2022; and (v) Notes to the Condensed Consolidated Financial Statements, tagged as blocks of text.
104 |  | The cover page from the Company’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2023, formatted in Inline XBRL (included as Exhibit 101).

† | Filed herewith.

** | This certification is deemed not filed for purposes of Section 18 of the Exchange Act, or otherwise subject to the liability of that section, nor shall it be deemed incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act.

42

SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
Date: October 26, 2023

FTI CONSULTING, INC.
By: |  | /s/ Brendan Keating
|  | Brendan Keating
|  | Chief Accounting Officer and Controller
|  | (principal accounting officer)

43